Alan Breier - Publications

Affiliations: 
Lilly, Lilly, PA, United States 

436 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Paul SM, Breier A, Lieberman JA, Brannan SK, Sawchak S, Miller AC. Clinical Trial of New Drug for Schizophrenia. Reply. The New England Journal of Medicine. 384: e105. PMID 34161716 DOI: 10.1056/NEJMc2104965#sa2  1
2021 Brannan SK, Sawchak S, Miller AC, Lieberman JA, Paul SM, Breier A. Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia. The New England Journal of Medicine. 384: 717-726. PMID 33626254 DOI: 10.1056/NEJMoa2017015  1
2021 Frangou S, Modabbernia A, Williams SCR, Papachristou E, Doucet GE, Agartz I, Aghajani M, Akudjedu TN, Albajes-Eizagirre A, Alnaes D, Alpert KI, Andersson M, Andreasen NC, Andreassen OA, Asherson P, ... ... Breier A, et al. Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3-90 years. Human Brain Mapping. PMID 33595143 DOI: 10.1002/hbm.25364  1
2021 Dima D, Modabbernia A, Papachristou E, Doucet GE, Agartz I, Aghajani M, Akudjedu TN, Albajes-Eizagirre A, Alnaes D, Alpert KI, Andersson M, Andreasen NC, Andreassen OA, Asherson P, Banaschewski T, ... ... Breier A, et al. Subcortical volumes across the lifespan: Data from 18,605 healthy individuals aged 3-90 years. Human Brain Mapping. PMID 33570244 DOI: 10.1002/hbm.25320  1
2021 Dickerson F, Katsafanas E, Origoni A, Squire A, Khushalani S, Newman T, Rowe K, Stallings C, Savage CLG, Sweeney K, Nguyen TT, Breier A, Goff D, Ford G, Jones-Brando L, et al. Exposure to Epstein Barr virus and cognitive functioning in individuals with schizophrenia. Schizophrenia Research. 228: 193-197. PMID 33450604 DOI: 10.1016/j.schres.2020.12.018  0.01
2020 Wierenga LM, Doucet GE, Dima D, Agartz I, Aghajani M, Akudjedu TN, Albajes-Eizagirre A, Alnaes D, Alpert KI, Andreassen OA, Anticevic A, Asherson P, Banaschewski T, Bargallo N, Baumeister S, ... ... Breier A, et al. Greater male than female variability in regional brain structure across the lifespan. Human Brain Mapping. PMID 33044802 DOI: 10.1002/hbm.25204  1
2020 Francis MM, Hummer TA, Liffick E, Vohs JL, Mehdiyoun NF, Visco AC, Yang Z, Kovacs RJ, Zhang Y, Breier A. Effects of fingolimod, a sphingosine-1-phosphate (S1P) receptor agonist, on white matter microstructure, cognition and symptoms in schizophrenia. Brain Imaging and Behavior. PMID 32893328 DOI: 10.1007/S11682-020-00375-7  1
2020 Bartolomeo LA, Shin YW, Block HJ, Bolbecker AR, Breier AF, O'Donnell B, Hetrick WP. Prism Adaptation Deficits in Schizophrenia. Schizophrenia Bulletin. PMID 32185380 DOI: 10.1093/Schbul/Sbaa019  1
2020 Hummer TA, Yung MG, Goñi J, Conroy SK, Francis MM, Mehdiyoun NF, Breier A. Functional network connectivity in early-stage schizophrenia. Schizophrenia Research. PMID 32037204 DOI: 10.1016/J.Schres.2020.01.023  1
2019 Leonhardt BL, Vohs JL, Bartolomeo LA, Visco A, Hetrick WP, Bolbecker AR, Breier A, Lysaker PH, O'Donnell BF. Relationship of Metacognition and Insight to Neural Synchronization and Cognitive Function in Early Phase Psychosis. Clinical Eeg and Neuroscience. 1550059419857971. PMID 31241355 DOI: 10.1177/1550059419857971  1
2019 Bartolomeo LA, Wright AM, Ma RE, Hummer TA, Francis MM, Visco AC, Mehdiyoun NF, Bolbecker AR, Hetrick WP, Dydak U, Barnard J, O'Donnell BF, Breier A. Relationship of auditory electrophysiological responses to magnetic resonance spectroscopy metabolites in Early Phase Psychosis. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. PMID 31129143 DOI: 10.1016/J.Ijpsycho.2019.05.009  1
2018 Breier A, Buchanan RW, D'Souza D, Nuechterlein K, Marder S, Dunn W, Preskorn S, Macaluso M, Wurfel B, Maguire G, Kakar R, Highum D, Hoffmeyer D, Coskinas E, Litman R, et al. Herpes simplex virus 1 infection and valacyclovir treatment in schizophrenia: Results from the VISTA study. Schizophrenia Research. PMID 30478008 DOI: 10.1016/J.Schres.2018.11.002  1
2018 Francis MM, Hummer TA, Vohs JL, Yung MG, Visco AC, Mehdiyoun NF, Kulig TC, Um M, Yang Z, Motamed M, Liffick E, Zhang Y, Breier A. Cognitive effects of bilateral high frequency repetitive transcranial magnetic stimulation in early phase psychosis: a pilot study. Brain Imaging and Behavior. PMID 29855992 DOI: 10.1007/S11682-018-9902-4  1
2018 Firmin RL, Lysaker PH, Luther L, Yanos PT, Leonhardt B, Breier A, Vohs JL. Internalized stigma in adults with early phase versus prolonged psychosis. Early Intervention in Psychiatry. PMID 29602244 DOI: 10.1111/Eip.12553  1
2018 Breier A, Liffick E, Hummer TA, Vohs JL, Yang Z, Mehdiyoun NF, Visco AC, Metzler E, Zhang Y, Francis MM. Effects of 12-month, double-blind N-acetyl cysteine on symptoms, cognition and brain morphology in early phase schizophrenia spectrum disorders. Schizophrenia Research. PMID 29588126 DOI: 10.1016/J.Schres.2018.03.012  1
2017 Vohs JL, Leonhardt BL, James AV, Francis MM, Breier A, Mehdiyoun N, Visco AC, Lysaker PH. Metacognitive Reflection and Insight Therapy for Early Psychosis: A preliminary study of a novel integrative psychotherapy. Schizophrenia Research. PMID 29108671 DOI: 10.1016/J.Schres.2017.10.041  1
2017 Schnakenberg Martin AM, Bartolomeo L, Howell J, Hetrick WP, Bolbecker AR, Breier A, Kidd G, O'Donnell BF. Auditory feature perception and auditory hallucinatory experiences in schizophrenia spectrum disorder. European Archives of Psychiatry and Clinical Neuroscience. PMID 28936548 DOI: 10.1007/s00406-017-0839-1  1
2017 Francis MM, Hummer TA, Leonhardt BL, Vohs JL, Yung MG, Mehdiyoun NF, Lysaker PH, Breier A. Association of medial prefrontal resting state functional connectivity and metacognitive capacity in early phase psychosis. Psychiatry Research. 262: 8-14. PMID 28208070 DOI: 10.1016/J.Pscychresns.2016.12.014  1
2016 Wright A, Ma R, Hummer T, Francis M, Mehdiyoun N, Dydak U, Breier A. SU-F-SPS-07: Magnetic Resonance Spectroscopy Findings in Early-Phase Psychosis. Medical Physics. 43: 3351. PMID 28047652 DOI: 10.1118/1.4955682  0.01
2016 Liffick E, Mehdiyoun NF, Vohs JL, Francis MM, Breier A. Utilization and Cost of Health Care Services During the First Episode of Psychosis. Psychiatric Services (Washington, D.C.). appips201500375. PMID 27691375 DOI: 10.1176/Appi.Ps.201500375  1
2016 Rao KN, Sentir AM, Engleman EA, Bell RL, Hulvershorn LA, Breier A, Chambers RA. Toward early estimation and treatment of addiction vulnerability: radial arm maze and N-acetyl cysteine before cocaine sensitization or nicotine self-administration in neonatal ventral hippocampal lesion rats. Psychopharmacology. PMID 27640177 DOI: 10.1007/S00213-016-4421-8  1
2016 Hummer TA, Francis MM, Vohs JL, Liffick E, Mehdiyoun NF, Breier A. Characterization of white matter abnormalities in early-stage schizophrenia. Early Intervention in Psychiatry. PMID 27621217 DOI: 10.1111/Eip.12359  1
2016 Minor KS, Marggraf MP, Davis BJ, Mehdiyoun NF, Breier A. Affective Systems Induce Formal Thought Disorder in Early-Stage Psychosis. Journal of Abnormal Psychology. PMID 26999283 DOI: 10.1037/abn0000156  1
2015 Maiuri AR, Breier AB, Turkus JD, Ganey PE, Roth RA. Calcium Contributes to the Cytotoxic Interaction between Diclofenac and Cytokines. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 26609140 DOI: 10.1093/Toxsci/Kfv249  1
2015 Luther L, Lysaker PH, Firmin RL, Breier A, Vohs JL. Intrinsic motivation and amotivation in first episode and prolonged psychosis. Schizophrenia Research. PMID 26386901 DOI: 10.1016/J.Schres.2015.08.040  1
2015 Schröder C, Schwab F, Behnke M, Breier AC, Maechler F, Piening B, Dettenkofer M, Geffers C, Gastmeier P. Epidemiology of healthcare associated infections in Germany: Nearly 20 years of surveillance. International Journal of Medical Microbiology : Ijmm. 305: 799-806. PMID 26358916 DOI: 10.1016/j.ijmm.2015.08.034  0.01
2015 Bartekova M, Barancik M, Pokusa M, Prokopova B, Radosinska J, Rusnak A, Breier A, Jezova D. Molecular changes induced by repeated restraint stress in the heart: the effect of oxytocin receptor antagonist atosiban. Canadian Journal of Physiology and Pharmacology. 93: 827-34. PMID 26323039 DOI: 10.1139/cjpp-2015-0096  1
2015 Layer F, Sanchini A, Strommenger B, Cuny C, Breier AC, Proquitté H, Bührer C, Schenkel K, Bätzing-Feigenbaum J, Greutelaers B, Nübel U, Gastmeier P, Eckmanns T, Werner G. Molecular typing of toxic shock syndrome toxin-1- and Enterotoxin A-producing methicillin-sensitive Staphylococcus aureus isolates from an outbreak in a neonatal intensive care unit. International Journal of Medical Microbiology : Ijmm. 305: 790-8. PMID 26321006 DOI: 10.1016/j.ijmm.2015.08.033  0.01
2015 Hahner J, Hoyer M, Hillig S, Schulze-Tanzil G, Meyer M, Schröpfer M, Lohan A, Garbe LA, Heinrich G, Breier A. Diffusion chamber system for testing of collagen-based cell migration barriers for separation of ligament enthesis zones in tissue-engineered ACL constructs. Journal of Biomaterials Science. Polymer Edition. 1-15. PMID 26300365 DOI: 10.1080/09205063.2015.1076714  1
2015 Vohs JL, Hummer TA, Yung MG, Francis MM, Lysaker PH, Breier A. Metacognition in Early Phase Psychosis: Toward Understanding Neural Substrates. International Journal of Molecular Sciences. 16: 14640-54. PMID 26132568 DOI: 10.3390/Ijms160714640  1
2015 Messingerova L, Imrichova D, Kavcova H, Turakova K, Breier A, Sulova Z. Acute myeloid leukemia cells MOLM-13 and SKM-1 established for resistance by azacytidine are crossresistant to P-glycoprotein substrates. Toxicology in Vitro : An International Journal Published in Association With Bibra. 29: 1405-15. PMID 26009263 DOI: 10.1016/j.tiv.2015.05.011  0.01
2015 Imrichova D, Messingerova L, Seres M, Kavcova H, Pavlikova L, Coculova M, Breier A, Sulova Z. Selection of resistant acute myeloid leukemia SKM-1 and MOLM-13 cells by vincristine-, mitoxantrone- and lenalidomide-induced upregulation of P-glycoprotein activity and downregulation of CD33 cell surface exposure. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 77: 29-39. PMID 26002042 DOI: 10.1016/j.ejps.2015.05.022  0.01
2015 Messingerová L, Jonášová A, Barančik M, Poleková L, Šereš M, Gibalová L, Breier A, Sulová Z. Lenalidomide treatment induced the normalization of marker protein levels in blood plasma of patients with 5q-myelodysplastic syndrome. General Physiology and Biophysics. PMID 26001289 DOI: 10.4149/gpb_2015012  0.01
2015 Turáková K, Pavlíková L, Messingerová L, Lakatoš B, Breier A, Sulová Z. Reduced UDP-glucose levels are associated with P-glycoprotein over-expression in L1210 cells and limit glucosylceramide synthase activity Anticancer Research. 35: 2627-2634. PMID 25964538  1
2015 Maiuri AR, Breier AB, Gora LF, Parkins RV, Ganey PE, Roth RA. Cytotoxic Synergy Between Cytokines and NSAIDs Associated With Idiosyncratic Hepatotoxicity Is Driven by Mitogen-Activated Protein Kinases. Toxicological Sciences : An Official Journal of the Society of Toxicology. 146: 265-80. PMID 25953702 DOI: 10.1093/Toxsci/Kfv091  0.01
2015 Vohs JL, Lysaker PH, Liffick E, Francis MM, Leonhardt BL, James A, Buck KD, Hamm JA, Minor KS, Mehdiyoun N, Breier A. Metacognitive capacity as a predictor of insight in first-episode psychosis. The Journal of Nervous and Mental Disease. 203: 372-8. PMID 25900550 DOI: 10.1097/NMD.0000000000000291  1
2015 Daitx VV, Mezzalira J, Moraes Vda C, Breier AC, Cé J, Coelho JC. Comparing the alpha-galactosidase A biochemical properties from healthy individuals and Fabry disease patients. Clinica Chimica Acta; International Journal of Clinical Chemistry. 445: 60-4. PMID 25804996 DOI: 10.1016/j.cca.2015.03.014  1
2015 Francis MM, Hummer TA, Vohs JL, Yung MG, Liffick E, Mehdiyoun NF, Radnovich AJ, McDonald BC, Saykin AJ, Breier A. Functional neuroanatomical correlates of episodic memory impairment in early phase psychosis. Brain Imaging and Behavior. PMID 25749917 DOI: 10.1007/S11682-015-9357-9  1
2015 Beggs KM, Maiuri AR, Fullerton AM, Poulsen KL, Breier AB, Ganey PE, Roth RA. Trovafloxacin-induced replication stress sensitizes HepG2 cells to tumor necrosis factor-alpha-induced cytotoxicity mediated by extracellular signal-regulated kinase and ataxia telangiectasia and Rad3-related. Toxicology. 331: 35-46. PMID 25748550 DOI: 10.1016/J.Tox.2015.03.002  1
2015 Jarskog LF, Lowy MT, Grove RA, Keefe RS, Horrigan JP, Ball MP, Breier A, Buchanan RW, Carter CS, Csernansky JG, Goff DC, Green MF, Kantrowitz JT, Keshavan MS, Laurelle M, et al. A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy. Schizophrenia Research. 164: 136-42. PMID 25728831 DOI: 10.1016/J.Schres.2015.01.041  1
2015 Leistner R, Schröder C, Geffers C, Breier AC, Gastmeier P, Behnke M. Regional distribution of nosocomial infections due to ESBL-positive Enterobacteriaceae in Germany: data from the German National Reference Center for the Surveillance of Nosocomial Infections (KISS). Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 21: 255.e1-5. PMID 25658549 DOI: 10.1016/j.cmi.2014.07.015  1
2015 Hoyer M, Meier C, Breier A, Hahner J, Heinrich G, Drechsel N, Meyer M, Rentsch C, Garbe LA, Ertel W, Lohan A, Schulze-Tanzil G. In vitro characterization of self-assembled anterior cruciate ligament cell spheroids for ligament tissue engineering. Histochemistry and Cell Biology. 143: 289-300. PMID 25256666 DOI: 10.1007/s00418-014-1280-4  1
2015 Hahner J, Hinüber C, Breier A, Siebert T, Brünig H, Heinrich G. Adjusting the mechanical behavior of embroidered scaffolds to lapin anterior cruciate ligaments by varying the thread materials Textile Research Journal. 85: 1431-1444. DOI: 10.1177/0040517514566107  1
2015 Maiuri AR, Breier AB, Gora LFJ, Parkins RV, Ganey PE, Roth RA. Cytotoxic synergy between cytokines and NSAIDs associated with idiosyncratic hepatotoxicity is driven by mitogen-activated protein kinases Toxicological Sciences. 146: 265-280. DOI: 10.1093/toxsci/kfv091  1
2015 Messingerova L, Imrichova D, Kavcova H, Turakova K, Breier A, Sulova Z. Acute myeloid leukemia cells MOLM-13 and SKM-1 established for resistance by azacytidine are crossresistant to P-glycoprotein substrates Toxicology in Vitro. 29: 1405-1415. DOI: 10.1016/j.tiv.2015.05.011  1
2015 Schröder C, Schwab F, Behnke M, Breier AC, Maechler F, Piening B, Dettenkofer M, Geffers C, Gastmeier P. Epidemiology of healthcare associated infections in Germany: Nearly 20 years of surveillance International Journal of Medical Microbiology. DOI: 10.1016/j.ijmm.2015.08.034  1
2015 Layer F, Sanchini A, Strommenger B, Cuny C, Breier AC, Proquitté H, Bührer C, Schenkel K, Bätzing-Feigenbaum J, Greutelaers B, Nübel U, Gastmeier P, Eckmanns T, Werner G. Molecular typing of toxic shock syndrome toxin-1- and Enterotoxin A-producing methicillin-sensitive Staphylococcus aureus isolates from an outbreak in a neonatal intensive care unit International Journal of Medical Microbiology. DOI: 10.1016/j.ijmm.2015.08.033  1
2015 Imrichova D, Messingerova L, Seres M, Kavcova H, Pavlikova L, Coculova M, Breier A, Sulova Z. Selection of resistant acute myeloid leukemia SKM-1 and MOLM-13 cells by vincristine-, mitoxantrone- and lenalidomide-induced upregulation of P-glycoprotein activity and downregulation of CD33 cell surface exposure European Journal of Pharmaceutical Sciences. 77: 29-39. DOI: 10.1016/j.ejps.2015.05.022  1
2015 Breier AC. Embroidery technology for hard-tissue scaffolds Biomedical Textiles For Orthopaedic and Surgical Applications: Fundamentals, Applications and Tissue Engineering. 23-43. DOI: 10.1016/B978-1-78242-017-0.00002-7  1
2014 Hoyer M, Drechsel N, Meyer M, Meier C, Hinüber C, Breier A, Hahner J, Heinrich G, Rentsch C, Garbe LA, Ertel W, Schulze-Tanzil G, Lohan A. Embroidered polymer-collagen hybrid scaffold variants for ligament tissue engineering. Materials Science & Engineering. C, Materials For Biological Applications. 43: 290-9. PMID 25175216 DOI: 10.1016/j.msec.2014.07.010  1
2014 Breier A, Stetka J, Bohacova V, Macejova D, Brtko J, Sulova Z. Effect of 9-cis retinoic acid and all-trans retinoic acid in combination with verapamil on P-glycoprotein expression in L1210 cells. Neoplasma. 61: 553-65. PMID 25030439 DOI: 10.4149/neo_2014_068  1
2014 Imrichova D, Coculova M, Messingerova L, Sulova Z, Breier A. Vincristine-induced expression of P-glycoprotein in MOLM-13 and SKM-1 acute myeloid leukemia cell lines is associated with coexpression of nestin transcript. General Physiology and Biophysics. 33: 425-31. PMID 24968412 DOI: 10.4149/gpb_2014015  1
2014 Breier AC, Cé J, Coelho JC. Correlation of the levels of glycosaminoglycans between urine and dried urine in filter paper samples and their stability over time under different storage temperatures. Clinica Chimica Acta; International Journal of Clinical Chemistry. 433: 49-53. PMID 24613516 DOI: 10.1016/j.cca.2014.02.022  1
2014 Vohs JL, Lysaker PH, Francis MM, Hamm J, Buck KD, Olesek K, Outcalt J, Dimaggio G, Leonhardt B, Liffick E, Mehdiyoun N, Breier A. Metacognition, social cognition, and symptoms in patients with first episode and prolonged psychoses. Schizophrenia Research. 153: 54-9. PMID 24503175 DOI: 10.1016/j.schres.2014.01.012  1
2014 Bures C, Klatte T, Gilhofer M, Behnke M, Breier AC, Neuhold N, Hermann M. A prospective study on surgical-site infections in thyroid operation. Surgery. 155: 675-81. PMID 24502803 DOI: 10.1016/j.surg.2013.12.002  1
2014 Castilhos CD, Mezzalira J, Goldim MP, Daitx VV, Garcia Cda S, Andrade CV, Breier AC, Cé J, Mello AS, Coelho JC. Determination of the lysosomal hydrolase activity in blood collected on filter paper, an alternative to screen high risk populations. Gene. 536: 344-7. PMID 24342658 DOI: 10.1016/j.gene.2013.11.101  1
2014 Höhne S, Breier A, Jäger M, Hanke T, Worch H, Simon F. Heterogeneous cross-linking and sulphation of chitosan Macromolecular Symposia. 346: 66-72. DOI: 10.1002/masy.201400067  1
2014 Klüß R, Breier A, Heine N, Kramp T, May K, Östreich-Schmidt S, Zehetbauer M. Comparative measurements an effective instrument for the documentation of ones own performance | Vergleichsmessungen - Ein wirksames Instrument zur Dokumentation der eigenen Leistungsfähigkeit Ptb - Mitteilungen Forschen Und Prufen. 124: 36-40.  1
2013 Kim DJ, Bolbecker AR, Howell J, Rass O, Sporns O, Hetrick WP, Breier A, O'Donnell BF. Disturbed resting state EEG synchronization in bipolar disorder: A graph-theoretic analysis. Neuroimage. Clinical. 2: 414-23. PMID 24179795 DOI: 10.1016/J.Nicl.2013.03.007  1
2013 Birgand G, Lepelletier D, Baron G, Barrett S, Breier AC, Buke C, Markovic-Denic L, Gastmeier P, Kluytmans J, Lyytikainen O, Sheridan E, Szilagyi E, Tacconelli E, Troillet N, Ravaud P, et al. Agreement among healthcare professionals in ten European countries in diagnosing case-vignettes of surgical-site infections. Plos One. 8: e68618. PMID 23874690 DOI: 10.1371/journal.pone.0068618  1
2013 Simão F, Matté A, Breier AC, Kreutz F, Trindade VM, Netto CA, Salbego CG. Resveratrol prevents global cerebral ischemia-induced decrease in lipid content. Neurological Research. 35: 59-64. PMID 23317800 DOI: 10.1179/1743132812Y.0000000116  1
2013 Breier A, Gibalova L, Seres M, Barancik M, Sulova Z. New insight into p-glycoprotein as a drug target. Anti-Cancer Agents in Medicinal Chemistry. 13: 159-70. PMID 22931413  1
2012 Bubencíkova T, Cholujová D, Messingerová L, Mislovicova D, Seres M, Breier A, Sulova Z. Detection of glycomic alterations induced by overexpression of p-glycoprotein on the surfaces of L1210 cells using sialic acid binding lectins. International Journal of Molecular Sciences. 13: 15177-92. PMID 23203118 DOI: 10.3390/ijms131115177  1
2012 Gastmeier P, Behnke M, Breier AC, Piening B, Schwab F, Dettenkofer M, Geffers C. [Healthcare-associated infection rates: measuring and comparing. Experiences from the German National Nosocomial Infection Surveillance System (KISS) and from other surveillance systems]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 55: 1363-9. PMID 23114434 DOI: 10.1007/s00103-012-1551-y  1
2012 Goldim MP, Garcia Cda S, de Castilhos CD, Daitx VV, Mezzalira J, Breier AC, Cé J, Mello A, Andrade CV, Sartori N, Coelho JC. Screening of high-risk Gaucher disease patients in Brazil using miniaturized dried blood spots and leukocyte techniques. Gene. 508: 197-8. PMID 22884741 DOI: 10.1016/j.gene.2012.07.011  1
2012 Rass O, Forsyth JK, Bolbecker AR, Hetrick WP, Breier A, Lysaker PH, O'Donnell BF. Computer-assisted cognitive remediation for schizophrenia: a randomized single-blind pilot study. Schizophrenia Research. 139: 92-8. PMID 22682988 DOI: 10.1016/J.Schres.2012.05.016  1
2012 Ayalew M, Le-Niculescu H, Levey DF, Jain N, Changala B, Patel SD, Winiger E, Breier A, Shekhar A, Amdur R, Koller D, Nurnberger JI, Corvin A, Geyer M, Tsuang MT, et al. Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Molecular Psychiatry. 17: 887-905. PMID 22584867 DOI: 10.1038/Mp.2012.37  1
2012 Gastmeier P, Breier AC, Brandt C. Influence of laminar airflow on prosthetic joint infections: a systematic review. The Journal of Hospital Infection. 81: 73-8. PMID 22579079 DOI: 10.1016/j.jhin.2012.04.008  1
2012 Barancik M, Bohacova V, Gibalova L, Sedlak J, Sulova Z, Breier A. Potentiation of anticancer drugs: effects of pentoxifylline on neoplastic cells. International Journal of Molecular Sciences. 13: 369-82. PMID 22312258 DOI: 10.3390/ijms13010369  1
2012 Rass O, Forsyth JK, Krishnan GP, Hetrick WP, Klaunig MJ, Breier A, O'Donnell BF, Brenner CA. Auditory steady state response in the schizophrenia, first-degree relatives, and schizotypal personality disorder. Schizophrenia Research. 136: 143-9. PMID 22285558 DOI: 10.1016/J.Schres.2012.01.003  1
2012 Gibalová L, SereÅ¡ M, Rusnák A, Ditte P, Labudová M, Uhrík B, Pastorek J, Sedlák J, Breier A, Sulová Z. P-glycoprotein depresses cisplatin sensitivity in L1210 cells by inhibiting cisplatin-induced caspase-3 activation. Toxicology in Vitro : An International Journal Published in Association With Bibra. 26: 435-44. PMID 22269388 DOI: 10.1016/j.tiv.2012.01.014  1
2012 Kosi K, Breier A, Tar JK. Chaos patterns in a 3 Degree of Freedom control with Robust Fixed Point Transformation Cinti 2012 - 13th Ieee International Symposium On Computational Intelligence and Informatics, Proceedings. 131-135. DOI: 10.1109/CINTI.2012.6496747  1
2012 Gastmeier P, Breier AC, Sohr D, Geffers C. Prevention of surgical site infections - Results from 14 years of KISS (hospital infection surveillance system) | Prävention der postoperativen Wundinfektionen - Erkenntnisse aus 14 Jahren KISS (Krankenhausinfektionssurveillancesystem) Trauma Und Berufskrankheit. 1-5. DOI: 10.1007/s10039-011-1799-8  1
2012 Sulová Z, Brtko J, Macejová D, Breier A. Are nuclear receptors for retinoids involved in the control of the expression and activity of P-glycoprotein? Retinoic Acid: Structure, Mechanisms and Roles in Disease. 29-51.  1
2011 SereÅ¡ M, Cholujová D, Bubenčíkova T, Breier A, Sulová Z. Tunicamycin depresses P-glycoprotein glycosylation without an effect on its membrane localization and drug efflux activity in L1210 cells. International Journal of Molecular Sciences. 12: 7772-84. PMID 22174631 DOI: 10.3390/ijms12117772  1
2011 Breier AC, Brandt C, Sohr D, Geffers C, Gastmeier P. Laminar airflow ceiling size: no impact on infection rates following hip and knee prosthesis. Infection Control and Hospital Epidemiology. 32: 1097-102. PMID 22011537 DOI: 10.1086/662182  1
2011 Breier A. Anxiety disorders and antipsychotic drugs: a pressing need for more research. The American Journal of Psychiatry. 168: 1012-4. PMID 21969042 DOI: 10.1176/appi.ajp.2011.11071049  1
2011 Ahn WY, Rass O, Fridberg DJ, Bishara AJ, Forsyth JK, Breier A, Busemeyer JR, Hetrick WP, Bolbecker AR, O'Donnell BF. Temporal discounting of rewards in patients with bipolar disorder and schizophrenia. Journal of Abnormal Psychology. 120: 911-21. PMID 21875166 DOI: 10.1037/A0023333  1
2011 Roman J, Breier AR, Steppe M. Stability indicating LC method to determination of sodium montelukast in pharmaceutical dosage form and its photodegradation kinetics. Journal of Chromatographic Science. 49: 540-6. PMID 21801485  1
2011 Kreutz F, Frozza RL, Breier AC, de Oliveira VA, Horn AP, Pettenuzzo LF, Netto CA, Salbego CG, Trindade VM. Amyloid-β induced toxicity involves ganglioside expression and is sensitive to GM1 neuroprotective action. Neurochemistry International. 59: 648-55. PMID 21723896 DOI: 10.1016/j.neuint.2011.06.007  1
2011 Mönch N, Breier AC, Weitzel-Kage D, Gausmann P, Jaklin J, Gastmeier P, Geffers C. [How many hospital insurance claims are based on infection control failures?]. Deutsche Medizinische Wochenschrift (1946). 136: 1413-6. PMID 21713718 DOI: 10.1055/s-0031-1281529  1
2011 Gastmeier P, Sohr D, Breier A, Behnke M, Geffers C. Prolonged duration of operation: an indicator of complicated surgery or of surgical (mis)management? Infection. 39: 211-5. PMID 21509426 DOI: 10.1007/s15010-011-0112-x  1
2011 Barancik M, Breier A. α2 integrin as regulator of metastatic potential. Acta Pharmacologica Sinica. 32: 279. PMID 21372822 DOI: 10.1038/aps.2011.12  1
2011 Steinert T, Breier A, Flammer E. [Preventive medical checkups and consultations in people with schizophrenia and a comparison group of similar social status]. Psychiatrische Praxis. 38: 87-90. PMID 20848377 DOI: 10.1055/s-0030-1248553  1
2010 SereÅ¡ M, Ditte P, Breier A, Sulová Z. Effect of thapsigargin on P-glycoprotein-negative and P-glycoprotein-positive L1210 mouse leukaemia cells. General Physiology and Biophysics. 29: 396-401. PMID 21157003 DOI: 10.4149/gpb_2010_04_396  1
2010 Mezesova L, Bartekova M, Javorkova V, Vlkovicova J, Breier A, Vrbjar N. Effect of quercetin on kinetic properties of renal Na,K-ATPase in normotensive and hypertensive rats. Journal of Physiology and Pharmacology : An Official Journal of the Polish Physiological Society. 61: 593-8. PMID 21081803  1
2010 Sulová Z, Ditte P, Kurucová T, Poláková E, Rogozanová K, Gibalová L, Seres M, Skvarková L, Sedlák J, Pastorek J, Breier A. The presence of P-glycoprotein in L1210 cells directly induces down-regulation of cell surface saccharide targets of concanavalin A. Anticancer Research. 30: 3661-8. PMID 20944151  1
2010 Rentsch C, Rentsch B, Breier A, Spekl K, Jung R, Manthey S, Scharnweber D, Zwipp H, Biewener A. Long-bone critical-size defects treated with tissue-engineered polycaprolactone-co-lactide scaffolds: a pilot study on rats. Journal of Biomedical Materials Research. Part A. 95: 964-72. PMID 20824650 DOI: 10.1002/jbm.a.32878  1
2010 Dočolomanský P, Boháčová V, Barančík M, Breier A. Why the xanthine derivatives are used to study of P-glycoprotein-mediated multidrug resistance in L1210/VCR line cells. General Physiology and Biophysics. 29: 215-21. PMID 20817945 DOI: 10.4149/gpb_2010_03_215  1
2010 Barteková M, Carnická S, Pancza D, Ondrejcáková M, Breier A, Ravingerová T. Acute treatment with polyphenol quercetin improves postischemic recovery of isolated perfused rat hearts after global ischemia. Canadian Journal of Physiology and Pharmacology. 88: 465-71. PMID 20555415 DOI: 10.1139/y10-025  1
2010 Perlis RH, Adams DH, Fijal B, Sutton VK, Farmen M, Breier A, Houston JP. Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depression. The Journal of Clinical Psychiatry. 71: 599-605. PMID 20021991 DOI: 10.4088/JCP.08m04632gre  1
2010 Rentsch C, Rentsch B, Breier A, Hofmann A, Manthey S, Scharnweber D, Biewener A, Zwipp H. Evaluation of the osteogenic potential and vascularization of 3D poly(3)hydroxybutyrate scaffolds subcutaneously implanted in nude rats. Journal of Biomedical Materials Research. Part A. 92: 185-95. PMID 19170159 DOI: 10.1002/jbm.a.32314  1
2010 Muller MVM, Petry A, Vianna LP, Breier AC, Michelin-Tirelli K, Pires RF, Trindade VMT, Coelho JC. Quantification of glucosylceramide in plasma of Gaucher disease patients Brazilian Journal of Pharmaceutical Sciences. 46: 644-649.  1
2010 Liffick E, Breier A. Pharmacotherapy of first-episode schizophrenia Psychopharm Review. 45: 41-48.  1
2009 Gibalová L, Sedlák J, Labudová M, Barancík M, Reháková A, Breier A, Sulová Z. Multidrug resistant P-glycoprotein positive L1210/VCR cells are also cross-resistant to cisplatin via a mechanism distinct from P-glycoprotein-mediated drug efflux activity. General Physiology and Biophysics. 28: 391-403. PMID 20097962 DOI: 10.4149/pb_2009_04_391  1
2009 Sulová Z, Seres M, Barancík M, Gibalová L, Uhrík B, Poleková L, Breier A. Does any relationship exist between P-glycoprotein-mediated multidrug resistance and intracellular calcium homeostasis. General Physiology and Biophysics. 28: F89-95. PMID 20093732  1
2009 Flammer E, Breier A, Steinert T. Oral health and hygiene among persons with severe mental illness. Psychiatric Services (Washington, D.C.). 60: 1402; author reply 1. PMID 19797391 DOI: 10.1176/appi.ps.60.10.1402  1
2009 Goranov AI, Breier AM, Merrikh H, Grossman AD. YabA of Bacillus subtilis controls DnaA-mediated replication initiation but not the transcriptional response to replication stress. Molecular Microbiology. 74: 454-66. PMID 19737352 DOI: 10.1111/J.1365-2958.2009.06876.X  1
2009 Rentsch B, Hofmann A, Breier A, Rentsch C, Scharnweber D. Embroidered and surface modified polycaprolactone-co-lactide scaffolds as bone substitute: in vitro characterization. Annals of Biomedical Engineering. 37: 2118-28. PMID 19626441 DOI: 10.1007/s10439-009-9731-0  1
2009 Reichert FF, Azevedo MR, Breier A, Gerage AM. Physical activity and prevalence of hypertension in a population-based sample of Brazilian adults and elderly. Preventive Medicine. 49: 200-4. PMID 19555712 DOI: 10.1016/j.ypmed.2009.06.009  1
2009 Klymenko SV, Ilyenko IN, Golarnik NA, Maznichenko OL, Breier A, Bazyka DA. Membrane transport and apoptosis-related proteins in radiation-associated acute myeloid leukemia following the Chornobyl accident. General Physiology and Biophysics. 28: 63-9. PMID 19390138 DOI: 10.4149/gpb_2009_01_63  1
2009 Kane JM, Osuntokun O, Kryzhanovskaya LA, Xu W, Stauffer VL, Watson SB, Breier A. A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia. The Journal of Clinical Psychiatry. 70: 572-81. PMID 19323965 DOI: 10.4088/JCP.08m04421  1
2009 Sulová Z, Mislovicová D, Gibalová L, Vajcnerová Z, Poláková E, Uhrík B, Tylková L, Kovarova A, Sedlák J, Breier A. Vincristine-induced overexpression of P-glycoprotein in L1210 cells is associated with remodeling of cell surface saccharides. Journal of Proteome Research. 8: 513-20. PMID 19099507 DOI: 10.1021/Pr8007094  1
2009 Breier AM, Grossman AD. Dynamic association of the replication initiator and transcription factor DnaA with the Bacillus subtilis chromosome during replication stress. Journal of Bacteriology. 191: 486-93. PMID 19011033 DOI: 10.1128/Jb.01294-08  1
2009 Spann M, Lindborg S, Seaman J, Baker R, Dunayevich E, Breier A. Bayesian adaptive non-inferiority with safety assessment: retrospective case study to highlight potential benefits and limitations of the approach. Journal of Psychiatric Research. 43: 561-7. PMID 18804218 DOI: 10.1016/J.Jpsychires.2008.07.009  1
2009 Breier A. Nonuniform air flow and cooling in rack systems - Prediction by computational fluid dynamics Intelec, International Telecommunications Energy Conference (Proceedings). DOI: 10.1109/INTLEC.2009.5352026  1
2009 Breier A, Sohr D, Geffers C, Gastmeier P. Pathogens of nosocomial infections in intensive care units | Erreger nosokomialer Infektionen auf Intensivstation Intensivmedizin Und Notfallmedizin. 46: 220-227. DOI: 10.1007/s00390-009-0058-8  1
2009 Breier A, Shekhar A. Innovative therapeutics for schizophrenia Psychopharm Review. 44: 17-24.  1
2008 Seres M, Poláková E, Krizanová O, Hudecová S, Klymenko SV, Breier A, Sulová Z. Overexpression of P-glycoprotein in L1210/VCR cells is associated with changes in several endoplasmic reticulum proteins that may be partially responsible for the lack of thapsigargin sensitivity. General Physiology and Biophysics. 27: 211-21. PMID 18981537  1
2008 Hawkins KA, Keefe RS, Christensen BK, Addington J, Woods SW, Callahan J, Zipursky RB, Perkins DO, Tohen M, Breier A, McGlashan TH. Neuropsychological course in the prodrome and first episode of psychosis: findings from the PRIME North America Double Blind Treatment Study. Schizophrenia Research. 105: 1-9. PMID 18774696 DOI: 10.1016/J.Schres.2008.07.008  1
2008 Vianna LP, Delwing D, Kurek AG, Breier AC, Kreutz F, Chiarani F, Stefanello FM, Wyse AT, Trindade VM. Effects of chronic proline administration on lipid contents of rat brain. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 26: 567-73. PMID 18573634 DOI: 10.1016/j.ijdevneu.2008.05.004  1
2008 Ondrias K, Stasko A, Cacanyiova S, Sulova Z, Krizanova O, Kristek F, Malekova L, Knezl V, Breier A. H(2)S and HS(-) donor NaHS releases nitric oxide from nitrosothiols, metal nitrosyl complex, brain homogenate and murine L1210 leukaemia cells. Pflã¼Gers Archiv : European Journal of Physiology. 457: 271-9. PMID 18458940 DOI: 10.1007/S00424-008-0519-0  1
2008 Adams DH, Close S, Farmen M, Downing AM, Breier A, Houston JP. Dopamine receptor D3 genotype association with greater acute positive symptom remission with olanzapine therapy in predominately caucasian patients with chronic schizophrenia or schizoaffective disorder. Human Psychopharmacology. 23: 267-74. PMID 18320559 DOI: 10.1002/hup.930  1
2008 Breier AR, Nudelman NS, Steppe M, Schapoval EE. Isolation and structure elucidation of photodegradation products of fexofenadine. Journal of Pharmaceutical and Biomedical Analysis. 46: 250-7. PMID 17977686 DOI: 10.1016/j.jpba.2007.09.017  1
2008 Sulová Z, Macejová D, Seres M, Sedlák J, Brtko J, Breier A. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity. Toxicology in Vitro : An International Journal Published in Association With Bibra. 22: 96-105. PMID 17920233 DOI: 10.1016/j.tiv.2007.08.011  1
2008 Patel JK, Pinals DA, Breier A, First MB. Schizophrenia and Other Psychoses Psychiatry: Third Edition. 1: 1201-1282. DOI: 10.1002/9780470515167.ch65  1
2007 Hoffman RE, Woods SW, Hawkins KA, Pittman B, Tohen M, Preda A, Breier A, Glist J, Addington J, Perkins DO, McGlashan TH. Extracting spurious messages from noise and risk of schizophrenia-spectrum disorders in a prodromal population. The British Journal of Psychiatry : the Journal of Mental Science. 191: 355-6. PMID 17906248 DOI: 10.1192/Bjp.Bp.106.031195  1
2007 Stefanello FM, Kreutz F, Scherer EB, Breier AC, Vianna LP, Trindade VM, Wyse AT. Reduction of gangliosides, phospholipids and cholesterol content in cerebral cortex of rats caused by chronic hypermethioninemia. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 25: 473-7. PMID 17890041 DOI: 10.1016/j.ijdevneu.2007.08.004  1
2007 Houston JP, Adams DH, Kirkwood SC, Farmen M, Downing AM, Breier A. Neuroreceptor gene polymorphisms and olanzapine depressive symptom response in schizophrenia. Journal of Clinical Psychopharmacology. 27: 520-3. PMID 17873692 DOI: 10.1097/Jcp.0B013E31814F4D82  1
2007 Malekova L, Tomaskova J, Novakova M, Stefanik P, Kopacek J, Lakatos B, Pastorekova S, Krizanova O, Breier A, Ondrias K. Inhibitory effect of DIDS, NPPB, and phloretin on intracellular chloride channels. Pflã¼Gers Archiv : European Journal of Physiology. 455: 349-57. PMID 17611769 DOI: 10.1007/S00424-007-0300-9  1
2007 Breier A, Alphs L, Binneman B. Wayne Fenton's impact on industry. Schizophrenia Bulletin. 33: 1154-5. PMID 17562696 DOI: 10.1093/schbul/sbm068  1
2007 Breier AM, Grossman AD. Whole-genome analysis of the chromosome partitioning and sporulation protein Spo0J (ParB) reveals spreading and origin-distal sites on the Bacillus subtilis chromosome. Molecular Microbiology. 64: 703-18. PMID 17462018 DOI: 10.1111/J.1365-2958.2007.05690.X  1
2007 Perry EB, Cramer JA, Cho HS, Petrakis IL, Karper LP, Genovese A, O'Donnell E, Krystal JH, D'Souza DC. Psychiatric safety of ketamine in psychopharmacology research. Psychopharmacology. 192: 253-60. PMID 17458544 DOI: 10.1007/S00213-007-0706-2  1
2007 de Aguirres AB, Mello PA, Andrade CM, Breier AC, Margis R, Guaragna RM, Borojevic R, Guma FC, Trindade VM. Variations of ganglioside biosynthetic pathways in the phenotype conversion from myofibroblasts to lipocytes in murine hepatic stellate cell line. Molecular and Cellular Biochemistry. 303: 121-30. PMID 17440688 DOI: 10.1007/S11010-007-9464-Z  1
2007 Hudecova S, Kubovcakova L, Kvetnansky R, Kopacek J, Pastorekova S, Novakova M, Knezl V, Tarabova B, Lacinova L, Sulova Z, Breier A, Jurkovicova D, Krizanova O. Modulation of expression of Na+/Ca2+ exchanger in heart of rat and mouse under stress. Acta Physiologica (Oxford, England). 190: 127-36. PMID 17394575 DOI: 10.1111/j.1748-1716.2007.01673.x  1
2007 Breier AR, Steppe M, Schapoval EES. Validation of UV spectrophotometric method for fexofenadine hydrochloride in pharmaceutical formulations and comparison with HPLC Analytical Letters. 40: 2329-2337. DOI: 10.1080/00032710701576023  1
2006 Breier A, Bohácová V, Docolomanský P. Inhibition of (Na(+)/K(+))-ATPase by Cibacron Blue 3G-A and its analogues. General Physiology and Biophysics. 25: 439-53. PMID 17356235  1
2006 Uhrík B, El-Saggan AH, Seres M, Gibalová L, Breier A, Sulová Z. Structural differences between sensitive and resistant L1210 cells. General Physiology and Biophysics. 25: 427-38. PMID 17356234  1
2006 Vaucher LC, Breier AR, Schapoval EE. Microbiological assay for the determination of telithromycin in tablets. Journal of Aoac International. 89: 1398-402. PMID 17042191  1
2006 Barancík M, Bohácová V, Sedlák J, Sulová Z, Breier A. LY294,002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 29: 426-34. PMID 17010577 DOI: 10.1016/j.ejps.2006.08.006  1
2006 Bohácová V, Sulová Z, Dovinová I, Poláková E, Barancík M, Uhrík B, Orlický J, Breier A. L1210 cells cultivated under the selection pressure of doxorubicin or vincristine express common mechanisms of multidrug resistance based on the overexpression of P-glycoprotein. Toxicology in Vitro : An International Journal Published in Association With Bibra. 20: 1560-8. PMID 16962737 DOI: 10.1016/J.Tiv.2006.07.011  1
2006 McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW, Hawkins KA, Hoffman RE, Preda A, Epstein I, Addington D, Lindborg S, Trzaskoma Q, Tohen M, Breier A. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. The American Journal of Psychiatry. 163: 790-9. PMID 16648318 DOI: 10.1176/Ajp.2006.163.5.790  1
2006 Carlson C, Hornbuckle K, DeLisle F, Kryzhanovskaya L, Breier A, Cavazzoni P. Diabetes mellitus and antipsychotic treatment in the United Kingdom. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 16: 366-75. PMID 16356695 DOI: 10.1016/J.Euroneuro.2005.11.002  1
2006 Keefe RS, Young CA, Rock SL, Purdon SE, Gold JM, Breier A. One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia. Schizophrenia Research. 81: 1-15. PMID 16202565 DOI: 10.1016/J.Schres.2005.07.038  1
2006 Breier AR, Steppe M, Schapoval EES. Photodegradation kinetics of fexofenadine hydrochloride using a LC method Chromatographia. 64: 725-729. DOI: 10.1365/s10337-006-0096-3  1
2005 Docolomanský P, Fialová I, Barancík M, Rybár A, Breier A. Prolongation of pentoxifylline aliphatic side chain positively affects the reversal of P-glycoprotein-mediated multidrug resistance in L1210/VCR line cells. General Physiology and Biophysics. 24: 461-6. PMID 16474189  1
2005 Chou KL, Messing S, Oakes D, Feldman PD, Breier A, Friedman JH. Drug-induced psychosis in Parkinson disease: phenomenology and correlations among psychosis rating instruments. Clinical Neuropharmacology. 28: 215-9. PMID 16239760 DOI: 10.1097/01.Wnf.0000180228.77802.32  1
2005 Breier A, Berg PH, Thakore JH, Naber D, Gattaz WF, Cavazzoni P, Walker DJ, Roychowdhury SM, Kane JM. Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia. The American Journal of Psychiatry. 162: 1879-87. PMID 16199834 DOI: 10.1176/Appi.Ajp.162.10.1879  1
2005 Breier A, Barancík M, Sulová Z, Uhrík B. P-glycoprotein--implications of metabolism of neoplastic cells and cancer therapy. Current Cancer Drug Targets. 5: 457-68. PMID 16178819 DOI: 10.2174/1568009054863636  1
2005 Breier AR, Garcia SS, Jablonski A, Steppe M, Schapoval EE. Capillary electrophoresis method for fexofenadine hydrochloride in capsules. Journal of Aoac International. 88: 1059-63. PMID 16152920  1
2005 Breier A. Developing drugs for cognitive impairment in schizophrenia. Schizophrenia Bulletin. 31: 816-22. PMID 16150959 DOI: 10.1093/schbul/sbi051  1
2005 Breier AR, Paim CS, Steppe M, Schapoval EE. Development and validation of dissolution tests for fexofenadine hydrochloride capsules and coated tablets. Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society For Pharmaceutical Sciences, Sociã©Tã© Canadienne Des Sciences Pharmaceutiques. 8: 289-98. PMID 16124939  1
2005 Goranov AI, Katz L, Breier AM, Burge CB, Grossman AD. A transcriptional response to replication status mediated by the conserved bacterial replication protein DnaA. Proceedings of the National Academy of Sciences of the United States of America. 102: 12932-7. PMID 16120674 DOI: 10.1073/Pnas.0506174102  1
2005 Sulová Z, Orlický J, Fiala R, Dovinová I, Uhrík B, Seres M, Gibalová L, Breier A. Expression of P-glycoprotein in L1210 cells is linked with rise in sensitivity to Ca2+. Biochemical and Biophysical Research Communications. 335: 777-84. PMID 16098480 DOI: 10.1016/j.bbrc.2005.07.144  1
2005 Deberdt WG, Dysken MW, Rappaport SA, Feldman PD, Young CA, Hay DP, Lehman DL, Dossenbach M, Degenhardt EK, Breier A. Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 13: 722-30. PMID 16085789 DOI: 10.1176/appi.ajgp.13.8.722  1
2005 Camara JE, Breier AM, Brendler T, Austin S, Cozzarelli NR, Crooke E. Hda inactivation of DnaA is the predominant mechanism preventing hyperinitiation of Escherichia coli DNA replication. Embo Reports. 6: 736-41. PMID 16041320 DOI: 10.1038/Sj.Embor.7400467  1
2005 Silva de Lima M, de Jesus Mari J, Breier A, Maria Costa A, Pondé de Sena E, Hotopf M. Quality of life in schizophrenia: a multicenter, randomized, naturalistic, controlled trial comparing olanzapine to first-generation antipsychotics. The Journal of Clinical Psychiatry. 66: 831-8. PMID 16013897  1
2005 Manna D, Deng S, Breier AM, Higgins NP. Bacteriophage Mu targets the trinucleotide sequence CGG. Journal of Bacteriology. 187: 3586-8. PMID 15866949 DOI: 10.1128/Jb.187.10.3586-3588.2005  1
2005 Breier AM, Weier HU, Cozzarelli NR. Independence of replisomes in Escherichia coli chromosomal replication. Proceedings of the National Academy of Sciences of the United States of America. 102: 3942-7. PMID 15738384 DOI: 10.1073/Pnas.0500812102  1
2005 Haro JM, Edgell ET, Novick D, Alonso J, Kennedy L, Jones PB, Ratcliffe M, Breier A. Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study. Acta Psychiatrica Scandinavica. 111: 220-31. PMID 15701107 DOI: 10.1111/j.1600-0447.2004.00450.x  1
2005 Deberdt W, Winokur A, Cavazzoni PA, Trzaskoma QN, Carlson CD, Bymaster FP, Wiener K, Floris M, Breier A. Amantadine for weight gain associated with olanzapine treatment. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 15: 13-21. PMID 15572269 DOI: 10.1016/j.euroneuro.2004.03.005  1
2005 Krystal JH, Abi-Saab W, Perry E, D'Souza DC, Liu N, Gueorguieva R, McDougall L, Hunsberger T, Belger A, Levine L, Breier A. Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects. Psychopharmacology. 179: 303-9. PMID 15309376 DOI: 10.1007/S00213-004-1982-8  1
2005 Breier A. Computational fluid dynamics - A tool for optimized fan and blower design Intelec, International Telecommunications Energy Conference (Proceedings). 627-630. DOI: 10.1109/INTLEC.2005.335171  1
2004 Barteková M, Sulová Z, Pancza D, Ravingerová T, Stankovicová T, Styk J, Breier A. Proteins released from liver after ischaemia induced an elevation of heart resistance against ischaemia-reperfusion injury: 2. Beneficial effect of liver ischaemia in situ. General Physiology and Biophysics. 23: 489-97. PMID 15815082  1
2004 Orlický J, Sulová Z, Dovinová I, Fiala R, Zahradníková A, Breier A. Functional fluo-3/AM assay on P-glycoprotein transport activity in L1210/VCR cells by confocal microscopy. General Physiology and Biophysics. 23: 357-66. PMID 15638123  1
2004 Peter BJ, Arsuaga J, Breier AM, Khodursky AB, Brown PO, Cozzarelli NR. Genomic transcriptional response to loss of chromosomal supercoiling in Escherichia coli. Genome Biology. 5: R87. PMID 15535863 DOI: 10.1186/Gb-2004-5-11-R87  1
2004 Breier AR, Paim CS, Menegola J, Steppe M, Schapoval EE. Development and validation of a liquid chromatographic method for fexofenadine hydrochloride in capsules. Journal of Aoac International. 87: 1093-7. PMID 15493665  1
2004 Namjoshi MA, Risser R, Shi L, Tohen M, Breier A. Quality of life assessment in patients with bipolar disorder treated with olanzapine added to lithium or valproic acid. Journal of Affective Disorders. 81: 223-9. PMID 15337326 DOI: 10.1016/J.Jad.2003.07.005  1
2004 Mitropoulou V, Goodman M, Sevy S, Elman I, New AS, Iskander EG, Silverman JM, Breier A, Siever LJ. Effects of acute metabolic stress on the dopaminergic and pituitary-adrenal axis activity in patients with schizotypal personality disorder. Schizophrenia Research. 70: 27-31. PMID 15246460 DOI: 10.1016/j.schres.2003.10.008  1
2004 Manna D, Breier AM, Higgins NP. Microarray analysis of transposition targets in Escherichia coli: the impact of transcription. Proceedings of the National Academy of Sciences of the United States of America. 101: 9780-5. PMID 15210965 DOI: 10.1073/Pnas.0400745101  1
2004 Breier AM, Cozzarelli NR. Linear ordering and dynamic segregation of the bacterial chromosome. Proceedings of the National Academy of Sciences of the United States of America. 101: 9175-6. PMID 15199189 DOI: 10.1073/Pnas.0403722101  1
2004 Elman I, Rott D, Green AI, Langleben DD, Lukas SE, Goldstein DS, Breier A. Effects of pharmacological doses of 2-deoxyglucose on plasma catecholamines and glucose levels in patients with schizophrenia. Psychopharmacology. 176: 369-75. PMID 15179540 DOI: 10.1007/S00213-004-1890-Y  1
2004 Breier AM, Chatterji S, Cozzarelli NR. Prediction of Saccharomyces cerevisiae replication origins. Genome Biology. 5: R22. PMID 15059255 DOI: 10.1186/Gb-2004-5-4-R22  1
2004 Cavazzoni P, Mukhopadhyay N, Carlson C, Breier A, Buse J. Retrospective analysis of risk factors in patients with treatment-emergent diabetes during clinical trials of antipsychotic medications. The British Journal of Psychiatry. Supplement. 47: S94-101. PMID 15056601 DOI: 10.1192/Bjp.184.47.S94  1
2004 Hawkins KA, Addington J, Keefe RS, Christensen B, Perkins DO, Zipurksy R, Woods SW, Miller TJ, Marquez E, Breier A, McGlashan TH. Neuropsychological status of subjects at high risk for a first episode of psychosis. Schizophrenia Research. 67: 115-22. PMID 14984870 DOI: 10.1016/J.Schres.2003.08.007  1
2004 Zhao Z, Namjoshi M, Barber BL, Loosbrock DL, Tunis SL, Zhu B, Breier A. Economic outcomes associated with switching individuals with schizophrenia between risperidone and olanzapine: findings from a large US claims database. Cns Drugs. 18: 157-64. PMID 14871159 DOI: 10.2165/00023210-200418030-00002  1
2004 De Deyn PP, Carrasco MM, Deberdt W, Jeandel C, Hay DP, Feldman PD, Young CA, Lehman DL, Breier A. Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease. International Journal of Geriatric Psychiatry. 19: 115-26. PMID 14758577 DOI: 10.1002/gps.1032  1
2004 Kupsáková I, Rybár A, Docolomanský P, Drobná Z, Stein U, Walther W, Barancík M, Breier A. Reversal of P-glycoprotein mediated vincristine resistance of L1210/VCR cells by analogues of pentoxifylline. A QSAR study. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 21: 283-93. PMID 14757500 DOI: 10.1016/j.ejps.2003.10.019  1
2004 Simmons LA, Breier AM, Cozzarelli NR, Kaguni JM. Hyperinitiation of DNA replication in Escherichia coli leads to replication fork collapse and inviability. Molecular Microbiology. 51: 349-58. PMID 14756777 DOI: 10.1046/J.1365-2958.2003.03842.X  1
2004 Feldman PD, Hay LK, Deberdt W, Kennedy JS, Hutchins DS, Hay DP, Hardy TA, Hoffmann VP, Hornbuckle K, Breier A. Retrospective cohort study of diabetes mellitus and antipsychotic treatment in a geriatric population in the United States. Journal of the American Medical Directors Association. 5: 38-46. PMID 14706127 DOI: 10.1016/S1525-8610(04)70042-0  1
2004 Bitter I, Dossenbach MR, Brook S, Feldman PD, Metcalfe S, Gagiano CA, Füredi J, Bartko G, Janka Z, Banki CM, Kovacs G, Breier A. Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 28: 173-80. PMID 14687871 DOI: 10.1016/J.Pnpbp.2003.09.033  1
2003 Barteková M, Styk J, Pancza D, Kukan M, Seboková J, Breier A. Proteins released from liver after ischaemia induced an elevation of heart resistance against ischaemia-reperfusion injury: 1. Beneficial effect of protein fraction isolated from perfusate after ischaemia and reperfusion of liver. General Physiology and Biophysics. 22: 567-77. PMID 15113129  1
2003 Wright P, Lindborg SR, Birkett M, Meehan K, Jones B, Alaka K, Ferchland-Howe I, Pickard A, Taylor CC, Roth J, Battaglia J, Bitter I, Chouinard G, Morris PL, Breier A. Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatment. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 48: 716-21. PMID 14733451 DOI: 10.1177/070674370304801102  1
2003 Sowell M, Mukhopadhyay N, Cavazzoni P, Carlson C, Mudaliar S, Chinnapongse S, Ray A, Davis T, Breier A, Henry RR, Dananberg J. Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: a prospective, randomized study using the two-step hyperinsulinemic, euglycemic clamp. The Journal of Clinical Endocrinology and Metabolism. 88: 5875-80. PMID 14671184 DOI: 10.1210/Jc.2002-021884  1
2003 Tohen M, Goldberg JF, Gonzalez-Pinto Arrillaga AM, Azorin JM, Vieta E, Hardy-Bayle MC, Lawson WB, Emsley RA, Zhang F, Baker RW, Risser RC, Namjoshi MA, Evans AR, Breier A. A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania. Archives of General Psychiatry. 60: 1218-26. PMID 14662554 DOI: 10.1001/archpsyc.60.12.1218  1
2003 El-Saggan AH, Dovinová I, Sulová Z, Barancík M, Hunáková L, Breier A, Uhrík B. Hypoxia increases cell death in multidrug-resistant leukemia cells. Differences in viability and ultrastructure between sensitive and multidrug-resistant L1210 mouse leukemic cells under hypoxia. General Physiology and Biophysics. 22: 265-73. PMID 14661737  1
2003 Fiala R, Sulová Z, El-Saggan AH, Uhrík B, Liptaj T, Dovinová I, Hanusovská E, Drobná Z, Barancík M, Breier A. P-glycoprotein-mediated multidrug resistance phenotype of L1210/VCR cells is associated with decreases of oligo- and/or polysaccharide contents. Biochimica Et Biophysica Acta. 1639: 213-24. PMID 14636953 DOI: 10.1016/j.bbadis.2003.09.009  1
2003 Feldman PD, Kaiser CJ, Kennedy JS, Sutton VK, Tran PV, Tollefson GD, Zhang F, Breier A. Comparison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years. The Journal of Clinical Psychiatry. 64: 998-1004. PMID 14628974  1
2003 Kennedy JS, Jeste D, Kaiser CJ, Golshan S, Maguire GA, Tollefson G, Sanger T, Bymaster FP, Kinon BJ, Dossenbach M, Gilmore JA, Breier A. Olanzapine vs haloperidol in geriatric schizophrenia: analysis of data from a double-blind controlled trial. International Journal of Geriatric Psychiatry. 18: 1013-20. PMID 14618553 DOI: 10.1002/Gps.1007  1
2003 Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, Mitchell PB, Centorrino F, Risser R, Baker RW, Evans AR, Beymer K, Dube S, Tollefson GD, Breier A. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Archives of General Psychiatry. 60: 1079-88. PMID 14609883 DOI: 10.1001/archpsyc.60.11.1079  1
2003 Hardy T, Breier A. Patients on atypical antipsychotic drugs: another high-risk group for type 2 diabetes: response to Lean and Pajonk. Diabetes Care. 26: 3200-1. PMID 14578278 DOI: 10.2337/diacare.26.11.3200  1
2003 Elman I, Lukas S, Shoaf SE, Rott D, Adler C, Breier A. Effects of acute metabolic stress on the peripheral vasopressinergic system in schizophrenia. Journal of Psychopharmacology (Oxford, England). 17: 317-23. PMID 14513924 DOI: 10.1177/02698811030173014  1
2003 Woods SW, Breier A, Zipursky RB, Perkins DO, Addington J, Miller TJ, Hawkins KA, Marquez E, Lindborg SR, Tohen M, McGlashan TH. Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome. Biological Psychiatry. 54: 453-64. PMID 12915290 DOI: 10.1016/S0006-3223(03)00321-4  1
2003 Arango C, Breier A, McMahon R, Carpenter WT, Buchanan RW. The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumes. The American Journal of Psychiatry. 160: 1421-7. PMID 12900303 DOI: 10.1176/appi.ajp.160.8.1421  1
2003 Wright P, Meehan K, Birkett M, Lindborg SR, Taylor CC, Morris P, Breier A. A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy. Clinical Therapeutics. 25: 1420-8. PMID 12867218 DOI: 10.1016/S0149-2918(03)80129-7  1
2003 Buse JB, Cavazzoni P, Hornbuckle K, Hutchins D, Breier A, Jovanovic L. A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States. Journal of Clinical Epidemiology. 56: 164-70. PMID 12654411 DOI: 10.1016/S0895-4356(02)00588-7  1
2003 Cavazzoni P, Tanaka Y, Roychowdhury SM, Breier A, Allison DB. Nizatidine for prevention of weight gain with olanzapine: a double-blind placebo-controlled trial. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 13: 81-5. PMID 12650950 DOI: 10.1016/S0924-977X(02)00127-X  1
2003 Miller TJ, Zipursky RB, Perkins D, Addington J, Woods SW, Hawkins KA, Hoffman R, Preda A, Epstein I, Addington D, Lindborg S, Marquez E, Tohen M, Breier A, McGlashan TH. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample. Schizophrenia Research. 61: 19-30. PMID 12648732 DOI: 10.1016/S0920-9964(02)00440-1  1
2003 McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller TJ, Woods SW, Hawkins KA, Hoffman R, Lindborg S, Tohen M, Breier A. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design. Schizophrenia Research. 61: 7-18. PMID 12648731 DOI: 10.1016/S0920-9964(02)00439-5  1
2003 Garcia CV, Breier AR, Steppe M, Schapoval EE, Oppe TP. Determination of dexamethasone acetate in cream by HPLC. Journal of Pharmaceutical and Biomedical Analysis. 31: 597-600. PMID 12615249 DOI: 10.1016/S0731-7085(02)00695-7  1
2003 Sanger TM, Tohen M, Vieta E, Dunner DL, Bowden CL, Calabrese JR, Feldman PD, Jacobs TG, Breier A. Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling. Journal of Affective Disorders. 73: 155-61. PMID 12507748 DOI: 10.1016/S0165-0327(02)00334-8  1
2003 Breier A. Chinese questions - The composer Shi-Rui Zhu on the new music in China | Chinesische fragen - Der komponist Shi-Rui Zhu über die neue musik in China Musik Und Asthetik. 7: 102-107.  1
2002 Kupsáková I, Docolomanský P, Rybár A, Barancík M, Breier A. Carbonyl group of aliphatic side chain of pentoxifylline does not play role for P-glycoprotein antagonizing effect of pentoxifylline. General Physiology and Biophysics. 21: 471-8. PMID 12693718  1
2002 Breier A, Sutton VK, Feldman PD, Kadam DL, Ferchland I, Wright P, Friedman JH. Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson's disease. Biological Psychiatry. 52: 438-45. PMID 12242060 DOI: 10.1016/S0006-3223(02)01392-6  1
2002 Shi L, Namjoshi MA, Zhang F, Gandhi G, Edgell ET, Tohen M, Breier A, Haro JM. Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status. International Clinical Psychopharmacology. 17: 227-37. PMID 12177585 DOI: 10.1097/00004850-200209000-00003  1
2002 Drobná Z, Stein U, Walther W, Barancík M, Breier A. Pentoxifylline influences drug transport activity of P-glycoprotein and decreases mdrl gene expression in multidrug resistant mouse leukemic L1210/VCR cells. General Physiology and Biophysics. 21: 103-9. PMID 12168720  1
2002 Namjoshi MA, Rajamannar G, Jacobs T, Sanger TM, Risser R, Tohen MF, Breier A, Keck PE. Economic, clinical, and quality-of-life outcomes associated with olanzapine treatment in mania. Results from a randomized controlled trial. Journal of Affective Disorders. 69: 109-18. PMID 12103458 DOI: 10.1016/S0165-0327(01)00310-X  1
2002 Elman I, Goldstein DS, Green AI, Eisenhofer G, Folio CJ, Holmes CS, Pickar D, Breier A. Effects of risperidone on the peripheral noradrenegic system in patients with schizophrenia: a comparison with clozapine and placebo. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 293-300. PMID 12093603 DOI: 10.1016/S0893-133X(02)00314-7  1
2002 Breier AR, Garcia CV, Oppe TP, Steppe M, Schapoval EE. Microbiological assay for azithromycin in pharmaceutical formulations. Journal of Pharmaceutical and Biomedical Analysis. 29: 957-61. PMID 12093530  0.01
2002 Sowell MO, Mukhopadhyay N, Cavazzoni P, Shankar S, Steinberg HO, Breier A, Beasley CM, Dananberg J. Hyperglycemic clamp assessment of insulin secretory responses in normal subjects treated with olanzapine, risperidone, or placebo. The Journal of Clinical Endocrinology and Metabolism. 87: 2918-23. PMID 12050274 DOI: 10.1210/Jcem.87.6.8599  1
2002 Tohen M, Baker RW, Altshuler LL, Zarate CA, Suppes T, Ketter TA, Milton DR, Risser R, Gilmore JA, Breier A, Tollefson GA. Olanzapine versus divalproex in the treatment of acute mania. The American Journal of Psychiatry. 159: 1011-7. PMID 12042191 DOI: 10.1176/Appi.Ajp.159.6.1011  1
2002 Breier A, Meehan K, Birkett M, David S, Ferchland I, Sutton V, Taylor CC, Palmer R, Dossenbach M, Kiesler G, Brook S, Wright P. A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Archives of General Psychiatry. 59: 441-8. PMID 11982448  1
2002 Meehan KM, Wang H, David SR, Nisivoccia JR, Jones B, Beasley CM, Feldman PD, Mintzer JE, Beckett LM, Breier A. Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 494-504. PMID 11927174 DOI: 10.1016/S0893-133X(01)00365-7  1
2002 Adler CM, Malhotra AK, Elman I, Pickar D, Breier A. Amphetamine-induced dopamine release and post-synaptic specific binding in patients with mild tardive dyskinesia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 295-300. PMID 11850144 DOI: 10.1016/S0893-133X(01)00309-8  1
2002 Tohen M, Chengappa KN, Suppes T, Zarate CA, Calabrese JR, Bowden CL, Sachs GS, Kupfer DJ, Baker RW, Risser RC, Keeter EL, Feldman PD, Tollefson GD, Breier A. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Archives of General Psychiatry. 59: 62-9. PMID 11779284 DOI: 10.1001/Archpsyc.59.1.62  1
2002 Breier A, Schlenk M. Cooling of telecom systems - Thermal optimization using CFD methods Intelec, International Telecommunications Energy Conference (Proceedings). 486-490.  1
2001 Kisucká J, Barancík M, Bohácová V, Breier A. Reversal effect of specific inhibitors of extracellular-signal regulated protein kinase pathway on P-glycoprotein mediated vincristine resistance of L1210 cells. General Physiology and Biophysics. 20: 439-44. PMID 11989653  1
2001 Tohen M, Zhang F, Keck PE, Feldman PD, Risser RC, Tran PV, Breier A. Olanzapine versus haloperidol in schizoaffective disorder, bipolar type. Journal of Affective Disorders. 67: 133-40. PMID 11869760 DOI: 10.1016/S0165-0327(00)00303-7  1
2001 Kvackajová-Kisucká J, Barancík M, Breier A. Drug transporters and their role in multidrug resistance of neoplastic cells. General Physiology and Biophysics. 20: 215-37. PMID 11765214  1
2001 Mintzer J, Faison W, Street JS, Sutton VK, Breier A. Olanzapine in the treatment of anxiety symptoms due to Alzheimer's disease: a post hoc analysis. International Journal of Geriatric Psychiatry. 16: S71-7. PMID 11748790 DOI: 10.1002/1099-1166(200112)16:1+<::AID-GPS568>3.0.CO;2-M  1
2001 Street JS, Clark WS, Kadam DL, Mitan SJ, Juliar BE, Feldman PD, Breier A. Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in nursing home patients with Alzheimer's dementia. International Journal of Geriatric Psychiatry. 16: S62-70. PMID 11748789 DOI: 10.1002/1099-1166(200112)16:1+<::AID-GPS569>3.0.CO;2-J  1
2001 Kennedy JS, Bymaster FP, Schuh L, Calligaro DO, Nomikos G, Felder CC, Bernauer M, Kinon BJ, Baker RW, Hay D, Roth HJ, Dossenbach M, Kaiser C, Beasley CM, Holcombe JH, ... ... Breier A, et al. A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data. International Journal of Geriatric Psychiatry. 16: S33-61. PMID 11748788 DOI: 10.1002/1099-1166(200112)16:1+<::Aid-Gps571>3.0.Co;2-5  1
2001 Kennedy JS, Zagar A, Bymaster F, Nomikos G, Trzepacz PT, Gilmore JA, Rotelli MD, Breier A, Tollefson G. The central cholinergic system profile of olanzapine compared with placebo in Alzheimer's disease. International Journal of Geriatric Psychiatry. 16: S24-32. PMID 11748787 DOI: 10.1002/1099-1166(200112)16:1+<::AID-GPS570>3.0.CO;2-8  1
2001 Meehan K, Zhang F, David S, Tohen M, Janicak P, Small J, Koch M, Rizk R, Walker D, Tran P, Breier A. A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. Journal of Clinical Psychopharmacology. 21: 389-97. PMID 11476123 DOI: 10.1097/00004714-200108000-00006  1
2001 Barancík M, Bohácová V, Kvackajová J, Hudecová S, Krizanová O, Breier A. SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 14: 29-36. PMID 11457647  0.01
2001 Wright P, Birkett M, David SR, Meehan K, Ferchland I, Alaka KJ, Saunders JC, Krueger J, Bradley P, San L, Bernardo M, Reinstein M, Breier A. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. The American Journal of Psychiatry. 158: 1149-51. PMID 11431240 DOI: 10.1176/appi.ajp.158.7.1149  1
2001 Elman I, Goldstein DS, Adler CM, Shoaf SE, Breier A. Inverse relationship between plasma epinephrine and testosterone levels during acute glucoprivation in healthy men. Life Sciences. 68: 1889-98. PMID 11292066 DOI: 10.1016/S0024-3205(01)00982-1  1
2001 Clark WS, Street JS, Feldman PD, Breier A. The effects of olanzapine in reducing the emergence of psychosis among nursing home patients with Alzheimer's disease. The Journal of Clinical Psychiatry. 62: 34-40. PMID 11235926  1
2001 Breier A. Introduction: a new era in the pharmacotherapy of psychotic disorders. The Journal of Clinical Psychiatry. 62: 3-5. PMID 11232750  1
2001 Tohen M, Jacobs TG, Grundy SL, McElroy SL, Banov MC, Janicak PG, Sanger T, Risser R, Zhang F, Toma V, Francis J, Tollefson GD, Breier A. Efficacy of olanzapine in acute bipolar mania - A double-blind, placebo-controlled study | Eficácia da olanzapina na fase aguda da mania bipolar - Um estudo duplocego, controlado por placebo Revista De Psiquiatria Clinica. 28: 218.  1
2000 Breier A, Ziegelhöffer A. "Lysine is the Lord", thought some scientists in regard to the group interacting with fluorescein isothiocyanate in ATP-binding sites of P-type ATPases but, is it not cysteine? General Physiology and Biophysics. 19: 253-63. PMID 11316056  1
2000 Edgell ET, Andersen SW, Johnstone BM, Dulisse B, Revicki D, Breier A. Olanzapine versus risperidone. A prospective comparison of clinical and economic outcomes in schizophrenia. Pharmacoeconomics. 18: 567-79. PMID 11227395 DOI: 10.2165/00019053-200018060-00004  1
2000 Bohácová V, Kvackajová J, Barancík M, Drobná Z, Breier A. Glutathione S-transferase does not play a role in multidrug resistance of L1210/VCR cell line. Physiological Research / Academia Scientiarum Bohemoslovaca. 49: 447-53. PMID 11072805  1
2000 David SR, Taylor CC, Kinon BJ, Breier A. The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia. Clinical Therapeutics. 22: 1085-96. PMID 11048906 DOI: 10.1016/S0149-2918(00)80086-7  1
2000 Street JS, Clark WS, Gannon KS, Cummings JL, Bymaster FP, Tamura RN, Mitan SJ, Kadam DL, Sanger TM, Feldman PD, Tollefson GD, Breier A. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group. Archives of General Psychiatry. 57: 968-76. PMID 11015815 DOI: 10.1001/Archpsyc.57.10.968  1
2000 Breier A, Buchanan RW, Irish D, Carpenter WT. Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns. 1993. Psychiatric Services (Washington, D.C.). 51: 1249-53. PMID 11013322 DOI: 10.1176/Appi.Ps.51.10.1249  1
2000 Hamilton SH, Edgell ET, Revicki DA, Breier A. Functional outcomes in schizophrenia: a comparison of olanzapine and haloperidol in a European sample. International Clinical Psychopharmacology. 15: 245-55. PMID 10993126  1
2000 Carpenter WT, Breier A, Buchanan RW, Kirkpatrick B, Shepard P, Weiner E. Mazindol treatment of negative symptoms. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 365-74. PMID 10989263 DOI: 10.1016/S0893-133X(00)00115-9  1
2000 Tohen M, Jacobs TG, Grundy SL, McElroy SL, Banov MC, Janicak PG, Sanger T, Risser R, Zhang F, Toma V, Francis J, Tollefson GD, Breier A. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Archives of General Psychiatry. 57: 841-9. PMID 10986547  1
2000 Breier A, Drobná Z, Docolomansky P, Barancik M. Cytotoxic activity of several unrelated drugs on L1210 mouse leukemic cell sublines with P-glycoprotein (PGP) mediated multidrug resistance (MDR) phenotype. A QSAR study. Neoplasma. 47: 100-6. PMID 10985475  1
2000 Ziegelhöffer A, Kjeldsen K, Bundgaard H, Breier A, Vrbjar N, Dzurba A. Na,K-ATPase in the myocardium: molecular principles, functional and clinical aspects. General Physiology and Biophysics. 19: 9-47. PMID 10930137  0.01
2000 Gómez JC, Sacristán JA, Hernández J, Breier A, Ruiz Carrasco P, Antón Saiz C, Fontova Carbonell E. The safety of olanzapine compared with other antipsychotic drugs: results of an observational prospective study in patients with schizophrenia (EFESO Study). Pharmacoepidemiologic Study of Olanzapine in Schizophrenia. The Journal of Clinical Psychiatry. 61: 335-43. PMID 10847307  1
2000 Lauderback CM, Breier AM, Hackett J, Varadarajan S, Goodlett-Mercer J, Butterfield DA. The pyrrolopyrimidine U101033E is a potent free radical scavenger and prevents Fe(II)-induced lipid peroxidation in synaptosomal membranes. Biochimica Et Biophysica Acta. 1501: 149-61. PMID 10838188 DOI: 10.1016/S0925-4439(00)00015-6  1
2000 Adler CM, Elman I, Weisenfeld N, Kestler L, Pickar D, Breier A. Effects of acute metabolic stress on striatal dopamine release in healthy volunteers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 545-50. PMID 10731630 DOI: 10.1016/S0920-9964(00)90629-7  1
2000 Watabe H, Endres CJ, Breier A, Schmall B, Eckelman WC, Carson RE. Measurement of dopamine release with continuous infusion of [11C]raclopride: optimization and signal-to-noise considerations. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 41: 522-30. PMID 10716328  1
2000 Purdon SE, Jones BD, Stip E, Labelle A, Addington D, David SR, Breier A, Tollefson GD. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia. Archives of General Psychiatry. 57: 249-58. PMID 10711911 DOI: 10.1001/ARCHPSYC.57.3.249  1
2000 Bertolino A, Breier A, Callicott JH, Adler C, Mattay VS, Shapiro M, Frank JA, Pickar D, Weinberger DR. The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 125-32. PMID 10649825 DOI: 10.1016/S0893-133X(99)00096-2  1
2000 Kestler LP, Malhotra AK, Finch C, Adler C, Breier A. The relation between dopamine D2 receptor density and personality: preliminary evidence from the NEO personality inventory-revised. Neuropsychiatry, Neuropsychology, and Behavioral Neurology. 13: 48-52. PMID 10645736  1
1999 Breier A. Notes on the reform of scientific work assessment systems in post-communist countries. General Physiology and Biophysics. 18: 321-2. PMID 10766030  1
1999 Adler CM, Malhotra AK, Elman I, Goldberg T, Egan M, Pickar D, Breier A. Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. The American Journal of Psychiatry. 156: 1646-9. PMID 10518181 DOI: 10.1176/Ajp.156.10.1646  1
1999 Breier A, Berg PH. The psychosis of schizophrenia: prevalence, response to atypical antipsychotics, and prediction of outcome. Biological Psychiatry. 46: 361-4. PMID 10435201 DOI: 10.1016/S0006-3223(99)00040-2  1
1999 Kosmidis MH, Breier A, Fantie BD. Avoidance learning in schizophrenia: a dissociation between the effects of aversive and non-aversive stimuli. Schizophrenia Research. 38: 51-9. PMID 10427610 DOI: 10.1016/S0920-9964(98)00181-9  1
1999 Barancík M, Bohácová V, Zbýnovcová M, Breier A. Differential expression of regulatory proteins in L1210/VCR cells with multidrug resistance mediated by P-glycoprotein. General Physiology and Biophysics. 18: 45-56. PMID 10378120  1
1999 Rietschel M, Kennedy JL, Macciardi F, Meltzer HY. Application of pharmacogenetics to psychotic disorders: the first consensus conference. The Consensus Group for Outcome Measures in Psychoses for Pharmacological Studies. Schizophrenia Research. 37: 191-6. PMID 10374654 DOI: 10.1016/S0920-9964(98)00153-4  1
1999 Kubin T, Ando H, Scholz D, Bramlage P, Kostin S, van Veen A, Heling A, Hein S, Fischer S, Breier A, Schaper J, Schaper W. Microvascular endothelial cells remodel cultured adult cardiomyocytes and increase their survival. The American Journal of Physiology. 276: H2179-87. PMID 10362702  0.01
1999 Breier A. Cognitive deficit in schizophrenia and its neurochemical basis. The British Journal of Psychiatry. Supplement. 16-8. PMID 10211135 DOI: 10.1192/S0007125000293604  1
1999 Bryant NL, Buchanan RW, Vladar K, Breier A, Rothman M. Gender differences in temporal lobe structures of patients with schizophrenia: a volumetric MRI study. The American Journal of Psychiatry. 156: 603-9. PMID 10200741  1
1999 Breier A, Su TP, Malhotra AK, Elman I, Adler CM, Weisenfeld NI, Pickar D. Effects of atypical antipsychotic drug treatment on amphetamine-induced striatal dopamine release in patients with psychotic disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 20: 340-5. PMID 10088134 DOI: 10.1016/S0893-133X(98)00126-2  1
1999 Carpenter WT, Buchanan RW, Kirkpatrick B, Lann HD, Breier AF, Summerfelt AT. Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks. The American Journal of Psychiatry. 156: 412-8. PMID 10080557  1
1999 Breier A, Hamilton SH. Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia. Biological Psychiatry. 45: 403-11. PMID 10071708 DOI: 10.1016/S0006-3223(98)00291-1  1
1999 Carpenter WT, Buchanan RW, Kirkpatrick B, Breier AF. Diazepam treatment of early signs of exacerbation in schizophrenia. The American Journal of Psychiatry. 156: 299-303. PMID 9989567  1
1999 Breier AF, Malhotra AK, Su TP, Pinals DA, Elman I, Adler CM, Lafargue RT, Clifton A, Pickar D. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response. The American Journal of Psychiatry. 156: 294-8. PMID 9989566 DOI: 10.1176/Ajp.156.2.294  1
1999 Elman I, Goldstein DS, Eisenhofer G, Folio J, Malhotra AK, Adler CM, Pickar D, Breier A. Mechanism of peripheral noradrenergic stimulation by clozapine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 20: 29-34. PMID 9885782 DOI: 10.1016/S0893-133X(98)00047-5  1
1999 Elman I, Sokoloff L, Adler CM, Weisenfeld N, Breier A. The effects of pharmacological doses of 2-deoxyglucose on cerebral blood flow in healthy volunteers. Brain Research. 815: 243-9. PMID 9878763 DOI: 10.1016/S0006-8993(98)01137-8  1
1999 Breier A, Lieberman JA. Papers from the Symposium 'New Antipsychotic Drugs: Special Issues and Indications' 20-21 February, 1998 Marco Island, Florida. Introduction Schizophrenia Research. 35. DOI: 10.1016/S0920-9964(98)00157-1  1
1998 Breier A, Drobná Z, Barancík M. Direct interaction between verapamil and doxorubicin causes the lack of reversal effect of verapamil on P-glycoprotein mediated resistance to doxorubicin in vitro using L1210/VCR cells. Neoplasma. 45: 248-53. PMID 9890669  1
1998 Sulová Z, Vyskocil F, Stankovicová T, Breier A. Ca(2+)-induced inhibition of sodium pump: effects on energetic metabolism of mouse diaphragm tissue. General Physiology and Biophysics. 17: 271-83. PMID 9834848  1
1998 Bohácová V, Docolomanský P, Breier A, Gemeiner P, Ziegelhöffer A. Interaction of lactate dehydrogenase with anthraquinone dyes: characterization of ligands for dye-ligand chromatography. Journal of Chromatography. B, Biomedical Sciences and Applications. 715: 273-81. PMID 9792515 DOI: 10.1016/S0378-4347(98)00088-7  1
1998 Breier A, Sulová Z, Vrbanová A. Ca(2+)-induced inhibition of sodium pump: noncompetitive inhibition in respect of magnesium and sodium cations. General Physiology and Biophysics. 17: 179-88. PMID 9785104  1
1998 Malhotra AK, Breier A, Goldman D, Picken L, Pickar D. The apolipoprotein E epsilon 4 allele is associated with blunting of ketamine-induced psychosis in schizophrenia. A preliminary report. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 19: 445-8. PMID 9778666 DOI: 10.1016/S0893-133X(98)00031-1  1
1998 Breier A, Kestler L, Adler C, Elman I, Wiesenfeld N, Malhotra A, Pickar D. Dopamine D2 receptor density and personal detachment in healthy subjects. The American Journal of Psychiatry. 155: 1440-2. PMID 9766779 DOI: 10.1176/Ajp.155.10.1440  1
1998 Malhotra AK, Goldman D, Mazzanti C, Clifton A, Breier A, Pickar D. A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics. Molecular Psychiatry. 3: 328-32. PMID 9702741 DOI: 10.1038/Sj.Mp.4000412  1
1998 Elman I, Adler CM, Malhotra AK, Bir C, Pickar D, Breier A. Effect of acute metabolic stress on pituitary-adrenal axis activation in patients with schizophrenia. The American Journal of Psychiatry. 155: 979-81. PMID 9659871 DOI: 10.1176/Ajp.155.7.979  1
1998 Buchanan RW, Breier A, Kirkpatrick B, Ball P, Carpenter WT. Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome. The American Journal of Psychiatry. 155: 751-60. PMID 9619146  1
1998 Adler CM, Goldberg TE, Malhotra AK, Pickar D, Breier A. Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers. Biological Psychiatry. 43: 811-6. PMID 9611670 DOI: 10.1016/S0006-3223(97)00556-8  1
1998 Breier A, Adler CM, Weisenfeld N, Su TP, Elman I, Picken L, Malhotra AK, Pickar D. Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach. Synapse (New York, N.Y.). 29: 142-7. PMID 9593104 DOI: 10.1002/(Sici)1098-2396(199806)29:2<142::Aid-Syn5>3.0.Co;2-7  1
1998 Bertolino A, Callicott JH, Elman I, Mattay VS, Tedeschi G, Frank JA, Breier A, Weinberger DR. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biological Psychiatry. 43: 641-8. PMID 9582997 DOI: 10.1016/S0006-3223(97)00555-6  1
1998 Pinals DA, Malhotra AK, Breier A, Pickar D. Informed consent in schizophrenia research. Psychiatric Services (Washington, D.C.). 49: 244. PMID 9575016 DOI: 10.1176/Ps.49.2.244  1
1998 Malhotra AK, Goldman D, Buchanan RW, Rooney W, Clifton A, Kosmidis MH, Breier A, Pickar D. The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response. Molecular Psychiatry. 3: 72-5. PMID 9491816 DOI: 10.1038/Sj.Mp.4000288  1
1998 Breier A, Elman I, Goldstein DS. Norepinephrine and schizophrenia: a new hypothesis for antipsychotic drug action. Advances in Pharmacology (San Diego, Calif.). 42: 785-8. PMID 9328015 DOI: 10.1016/S1054-3589(08)60864-9  1
1998 Krystal J, Moghaddam B, Breier A, Goldman-Rakic P, McElvey J. 204. Glutamate, dopamine, the frontal cortex, and schizophrenia Biological Psychiatry. 43: S60. DOI: 10.1016/S0006-3223(98)90652-7  0.01
1998 Zbyňovská D, Breier A. Prediction of protein partition in aqueous polyethylene glycol/dextran two-phase system Chemical Papers. 52: 329-330.  1
1998 Ďurica M, Breier A. Synthesis and chemical properties of doxorubicin derivates Chemical Papers. 52: 515.  1
1998 Barančík M, Boháčová V, Breier A. Possible involvement of mitogen-activated protein kinases in the regulation of P-glycoprotein mediated multidrug resistance of L1210 mouse leukemic cells Chemical Papers. 52: 441.  1
1998 Kvačkajová J, Barteková M, Breier A. Purification of S100α protein from rat skeletal muscle Chemical Papers. 52: 328.  1
1998 Boháčová V, Breier A, Dočolomansky P, Gemeiner P. Nucleotide-binding sites of enzymes - Target of the interaction with anthraquinones Chemical Papers. 52: 341.  1
1998 Breier A, Drobná Z, Boháčová V, Barančík M. Resistance of L1210 mouse leukemic cell line characterized by overexpression of ATP dependent drug transporter to several drugs Chemical Papers. 52: 418-419.  1
1998 Dočolomanský P, Poledna J, Breier A, Gemeiner P. Detection of enzyme activity inhibition by substrate using flow micro-calorimeter - Enzyme thermistor Chemical Papers. 52: 353.  1
1997 Ziegelhöffer A, Ravingerová T, Styk J, Seboková J, Waczulíková I, Breier A, Dzurba A, Volkovová K, Cársky J, Turecký L. Mechanisms that may be involved in calcium tolerance of the diabetic heart. Molecular and Cellular Biochemistry. 176: 191-8. PMID 9406161  0.01
1997 Elman I, Breier A. Effects of acute metabolic stress on plasma progesterone and testosterone in male subjects: relationship to pituitary-adrenocortical axis activation. Life Sciences. 61: 1705-12. PMID 9363986 DOI: 10.1016/S0024-3205(97)00776-5  1
1997 Kirkpatrick B, Litman D, Kim JW, Vladar K, Breier A, Buchanan RW. Failure of fusion of the septum pellucidum and the heterogeneity of schizophrenia. The Journal of Nervous and Mental Disease. 185: 639-41. PMID 9345255 DOI: 10.1097/00005053-199710000-00008  1
1997 Su TP, Malhotra AK, Hadd K, Breier A, Pickar D. D2 dopamine receptor occupancy: a crossover comparison of risperidone with clozapine therapy in schizophrenic patients. Archives of General Psychiatry. 54: 972-3. PMID 9337781 DOI: 10.1001/Archpsyc.1997.01830220102017  1
1997 Malhotra AK, Adler CM, Kennison SD, Elman I, Pickar D, Breier A. Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine. Biological Psychiatry. 42: 664-8. PMID 9325559 DOI: 10.1016/S0006-3223(96)00546-X  1
1997 Pickar D, Malhotra AK, Rooney W, Breier A, Goldman D. Apolipoprotein E epsilon 4 and clinical phenotype in schizophrenia. Lancet. 350: 930-1. PMID 9314875 DOI: 10.1016/S0140-6736(05)63266-7  1
1997 Endres CJ, Kolachana BS, Saunders RC, Su T, Weinberger D, Breier A, Eckelman WC, Carson RE. Kinetic modeling of [11C]raclopride: combined PET-microdialysis studies. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 17: 932-42. PMID 9307606 DOI: 10.1097/00004647-199709000-00002  1
1997 Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D, Breier A. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 17: 141-50. PMID 9272481 DOI: 10.1016/S0893-133X(97)00036-5  1
1997 Breier A, Malhotra AK, Pinals DA, Weisenfeld NI, Pickar D. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. The American Journal of Psychiatry. 154: 805-11. PMID 9167508 DOI: 10.1176/Ajp.154.6.805  1
1997 Carson RE, Breier A, de Bartolomeis A, Saunders RC, Su TP, Schmall B, Der MG, Pickar D, Eckelman WC. Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 17: 437-47. PMID 9143226 DOI: 10.1097/00004647-199704000-00009  1
1997 Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, Weinberger DR, Weisenfeld N, Malhotra AK, Eckelman WC, Pickar D. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proceedings of the National Academy of Sciences of the United States of America. 94: 2569-74. PMID 9122236 DOI: 10.1073/Pnas.94.6.2569  1
1997 Waltrip RW, Buchanan RW, Carpenter WT, Kirkpatrick B, Summerfelt A, Breier A, Rubin SA, Carbone KM. Borna disease virus antibodies and the deficit syndrome of schizophrenia. Schizophrenia Research. 23: 253-7. PMID 9075304 DOI: 10.1016/S0920-9964(96)00114-4  1
1997 Buchanan RW, Strauss ME, Breier A, Kirkpatrick B, Carpenter WT. Attentional impairments in deficit and nondeficit forms of schizophrenia. The American Journal of Psychiatry. 154: 363-70. PMID 9054784 DOI: 10.1176/Ajp.154.3.363  1
1996 Breier A, Vrbanová A, Docolomanský P, Bohácová V, Ziegelhöffer A. Competitive inhibition of (Na/K)-ATPase by furylethylenes with respect to potassium ions. General Physiology and Biophysics. 15: 291-307. PMID 9088927  1
1996 Pinals DA, Malhotra AK, Missar CD, Pickar D, Breier A. Lack of gender differences in neuroleptic response in patients with schizophrenia. Schizophrenia Research. 22: 215-22. PMID 9000318 DOI: 10.1016/S0920-9964(96)00067-9  1
1996 Buchanan RW, Kirkpatrick B, Bryant N, Ball P, Breier A. Fluoxetine augmentation of clozapine treatment in patients with schizophrenia. The American Journal of Psychiatry. 153: 1625-7. PMID 8942462 DOI: 10.1176/Ajp.153.12.1625  1
1996 Pickar D, Su TP, Weinberger DR, Coppola R, Malhotra AK, Knable MB, Lee KS, Gorey J, Bartko JJ, Breier A, Hsiao J. Individual variation in D2 dopamine receptor occupancy in clozapine-treated patients. The American Journal of Psychiatry. 153: 1571-8. PMID 8942453 DOI: 10.1176/Ajp.153.12.1571  1
1996 Malhotra AK, Goldman D, Ozaki N, Rooney W, Clifton A, Buchanan RW, Breier A, Pickar D. Clozapine response and the 5HT2C Cys23Ser polymorphism. Neuroreport. 7: 2100-2. PMID 8930967 DOI: 10.1097/00001756-199609020-00007  1
1996 Dzurba A, Vrbjar N, Breier A, Ziegelhöffer A. The membrane effect of benfluron: modulation of the heart sarcolemmal (Na+, K+)-ATPase and Mg(2+)-ATPase activities. General Physiology and Biophysics. 15: 71-5. PMID 8902559  1
1996 Ziegelhöffer A, Ravingerová T, Dzurba A, Tribulová N, Slezák J, Breier A, Szekeres L. Prevention by 7-oxo-prostacyclin of the calcium paradox in rat heart: role of the sarcolemmal (Na,K)-ATPase. Molecular and Cellular Biochemistry. 160: 257-63. PMID 8901481  0.01
1996 Breier A, Ziegelhöffer A, Famulsky K, Michalak M, Slezák J. Is cysteine residue important in FITC-sensitive ATP-binding site of P-type ATPases? A commentary to the state of the art. Molecular and Cellular Biochemistry. 160: 89-93. PMID 8901460 DOI: 10.1007/Bf00240036  1
1996 Carpenter WT, Conley RR, Buchanan RW, Breier A, Tamminga CA. Clozapine conflict. The American Journal of Psychiatry. 153: 1505-7. PMID 8890695  1
1996 Ziegelhöffer A, Ravingerová T, Styk J, Tribulová N, Volkovová K, Seboková J, Breier A. Diabetic cardiomyopathy in rats: biochemical mechanisms of increased tolerance to calcium overload. Diabetes Research and Clinical Practice. 31: S93-103. PMID 8864647  0.01
1996 Stefanková Z, Barancík M, Breier A. Overcoming of P-glycoprotein mediated vincristine resistance of L1210/VCR mouse leukemic cells could be induced by pentoxifyline but not by theophylline and caffeine. Neoplasma. 43: 11-5. PMID 8843953  1
1996 Malhotra AK, Pinals DA, Weingartner H, Sirocco K, Missar CD, Pickar D, Breier A. NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 14: 301-7. PMID 8703299 DOI: 10.1016/0893-133X(95)00137-3  1
1996 Malhotra AK, Goldman D, Ozaki N, Breier A, Buchanan R, Pickar D. Lack of association between polymorphisms in the 5-HT2A receptor gene and the antipsychotic response to clozapine. The American Journal of Psychiatry. 153: 1092-4. PMID 8678181 DOI: 10.1176/Ajp.153.8.1092  1
1996 Malhotra AK, Goldman D, Buchanan R, Breier A, Pickar D. 5HT 2a receptor T102C polymorphism and schizophrenia. Lancet. 347: 1830-1. PMID 8667937 DOI: 10.1016/S0140-6736(96)91650-5  1
1996 Frazier JA, Giedd JN, Hamburger SD, Albus KE, Kaysen D, Vaituzis AC, Rajapakse JC, Lenane MC, McKenna K, Jacobsen LK, Gordon CT, Breier A, Rapoport JL. Brain anatomic magnetic resonance imaging in childhood-onset schizophrenia. Archives of General Psychiatry. 53: 617-24. PMID 8660128 DOI: 10.1001/Archpsyc.1996.01830070065010  1
1996 Bustillo JR, Buchanan RW, Irish D, Breier A. Differential effect of clozapine on weight: a controlled study. The American Journal of Psychiatry. 153: 817-9. PMID 8633697 DOI: 10.1176/Ajp.153.6.817  1
1996 Frazier JA, Giedd JN, Kaysen D, Albus K, Hamburger S, Alaghband-Rad J, Lenane MC, McKenna K, Breier A, Rapoport JL. Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment. The American Journal of Psychiatry. 153: 564-6. PMID 8599409 DOI: 10.1176/Ajp.153.4.564  1
1995 Barancík M, Stefanková Z, Breier A. Effect of phorbol myristate acetate (PMA) on P-glycoprotein mediated vincristine resistance of L1210 cells. General Physiology and Biophysics. 14: 171-5. PMID 8846884  1
1995 Hagarová D, Breier A. Distribution of proteins in aqueous two-phase systems formed by dextran and polyethylene glycol. Influence of protein hydrophobicity. General Physiology and Biophysics. 14: 277-91. PMID 8720692  1
1995 Waltrip RW, Buchanan RW, Summerfelt A, Breier A, Carpenter WT, Bryant NL, Rubin SA, Carbone KM. Borna disease virus and schizophrenia. Psychiatry Research. 56: 33-44. PMID 7792340 DOI: 10.1016/0165-1781(94)02600-N  1
1995 Stankovicová T, Zemková H, Breier A, Amler E, Burkhard M, Vyskocil F. The effects of calcium and calcium channel blockers on sodium pump. Pflã¼Gers Archiv : European Journal of Physiology. 429: 716-21. PMID 7792147  0.01
1995 Carpenter WT, Conley RR, Buchanan RW, Breier A, Tamminga CA. Patient response and resource management: another view of clozapine treatment of schizophrenia. The American Journal of Psychiatry. 152: 827-32. PMID 7755110 DOI: 10.1176/Ajp.152.6.827  1
1995 Schreiber JL, Breier A, Pickar D. Expressed emotion. Trait or state? The British Journal of Psychiatry : the Journal of Mental Science. 166: 647-9. PMID 7620751 DOI: 10.1192/Bjp.166.5.647  1
1995 Breier A. Serotonin, schizophrenia and antipsychotic drug action. Schizophrenia Research. 14: 187-202. PMID 7539288 DOI: 10.1016/0920-9964(94)00043-8  1
1995 Breier A, Ziegelhöffer A, Stankovicová T, Docolomanský P, Gemeiner P, Vrbanová A. Inhibition of (Na/K)-ATPase by electrophilic substances: functional implications. Molecular and Cellular Biochemistry. 147: 187-92. PMID 7494549  0.01
1995 Ziegelhöffer A, Vrbjar N, Styk J, Breier A, Dzurba A, Ravingerová T. Adaptation of the heart to ischemia by preconditioning: effects on energy equilibrium, properties of sarcolemmal ATPases and release of cardioprotective proteins. Molecular and Cellular Biochemistry. 147: 129-37. PMID 7494541  0.01
1995 Breier A, Gatzmanga H. Influence quantities to the volume flow rate to frequency characteristic of vortex meters at low reynold numbers Technisches Messen. 62: 22-26. DOI: 10.1524/teme.1995.62.jg.22  1
1995 Breier A. The management of treatment-resistant schizophrenia Current Opinion in Psychiatry. 8: 41-44. DOI: 10.1097/00001504-199501000-00010  1
1995 Dočolomanský P, Gemeiner P, Ziegelhöffer A, Breier A. Screening of binding properties of con-a immobilized on bead cellulose by flow microcalorimetry using invertase and anti-con-a antibody as reporting systems Analytical Letters. 28: 2585-2594. DOI: 10.1080/00032719508007411  1
1994 Breier A, Buchanan RW, Kirkpatrick B, Davis OR, Irish D, Summerfelt A, Carpenter WT. Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. The American Journal of Psychiatry. 151: 20-6. PMID 8267129 DOI: 10.1176/Ajp.151.1.20  1
1994 Breier A, Michalak M. 2,4,6-Trinitrobenzenesulfonic acid modification of the carboxyl-terminal region (C-domain) of calreticulin. Molecular and Cellular Biochemistry. 130: 19-28. PMID 8190118 DOI: 10.1007/Bf01084264  1
1994 Breier A, Buchanan RW, Waltrip RW, Listwak S, Holmes C, Goldstein DS. The effect of clozapine on plasma norepinephrine: relationship to clinical efficacy. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 10: 1-7. PMID 8179790 DOI: 10.1038/npp.1994.1  1
1994 Kirkpatrick B, Buchanan RW, Breier A, Carpenter WT. Depressive symptoms and the deficit syndrome of schizophrenia. The Journal of Nervous and Mental Disease. 182: 452-5. PMID 8040655  1
1994 Breier A. Clozapine and noradrenergic function: support for a novel hypothesis for superior efficacy. The Journal of Clinical Psychiatry. 55: 122-5. PMID 7961555  1
1994 Buchanan RW, Koeppl P, Breier A. Stability of neurological signs with clozapine treatment. Biological Psychiatry. 36: 198-200. PMID 7948457 DOI: 10.1016/0006-3223(94)91225-4  1
1994 Buchanan RW, Strauss ME, Kirkpatrick B, Holstein C, Breier A, Carpenter WT. Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia. Archives of General Psychiatry. 51: 804-11. PMID 7944870 DOI: 10.1001/archpsyc.1994.03950100052005  1
1994 Barancík M, Poleková L, Mrázová T, Breier A, Stankovicová T, Slezák J. Reversal effects of several Ca(2+)-entry blockers, neuroleptics and local anaesthetics on P-glycoprotein-mediated vincristine resistance of L1210/VCR mouse leukaemic cell line. Drugs Under Experimental and Clinical Research. 20: 13-8. PMID 7924890  0.01
1994 Uhrík B, Tribulová N, Klobusická M, Barancík M, Breier A. Characterization of morphological and histochemical changes induced by overexpression of P-glycoprotein in mouse leukemic cell line L1210. Neoplasma. 41: 83-8. PMID 7911560  1
1994 Elkashef AM, Buchanan RW, Gellad F, Munson RC, Breier A. Basal ganglia pathology in schizophrenia and tardive dyskinesia: an MRI quantitative study. The American Journal of Psychiatry. 151: 752-5. PMID 7909412  1
1994 Breier A, Stefanková Z, Barancík M, Tribulová N. Time dependence of [3H]-vincristine accumulation by L1210 mouse leukemic cells. Effect of P-glycoprotein overexpression. General Physiology and Biophysics. 13: 287-98. PMID 7890145  1
1994 Buchanan RW, Holstein C, Breier A. The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance. Biological Psychiatry. 36: 717-25. PMID 7858067 DOI: 10.1016/0006-3223(94)90082-5  1
1994 Breier A, Barancík M, Stefanková Z, Uhrík B, Tribulová N. Effect of pentoxifylline on P-glycoprotein mediated vincristine resistance of L1210 mouse leukemic cell line. Neoplasma. 41: 297-303. PMID 7854500  1
1994 Vrbanová A, Stankovicová T, Docolomanský P, Stefko I, Ziegelhöffer A, Breier A. Inhibition of (Na/K)-ATPase by NFE induces an increase in mechanical activity of perfused guinea-pig heart. General Physiology and Biophysics. 13: 433-41. PMID 7797051  0.01
1994 Gatzmanga H, Breier A. Investigations of influence quantities on flow rate to vortex frequency ratio in vortex meters Technisches Messen. 61: 359-364. DOI: 10.1524/teme.1994.61.jg.359  1
1994 Breier A, Hagarová D, Gemeiner P, Ziegelhöffer A. Estimation of the effective hydrophobicity of protiens: Re-evaluation of methods Biotechnology Techniques. 8: 915-920. DOI: 10.1007/BF02447739  1
1993 Kirkpatrick B, Buchanan RW, Breier A, Carpenter WT. Case identification and stability of the deficit syndrome of schizophrenia. Psychiatry Research. 47: 47-56. PMID 8516416 DOI: 10.1016/0165-1781(93)90054-K  1
1993 Buchanan RW, Breier A, Kirkpatrick B, Elkashef A, Munson RC, Gellad F, Carpenter WT. Structural abnormalities in deficit and nondeficit schizophrenia. The American Journal of Psychiatry. 150: 59-65. PMID 8417581 DOI: 10.1176/Ajp.150.1.59  1
1993 Schreiber JL, Breier A, Pickar D. Hospital vs. community. Hospital & Community Psychiatry. 44: 795. PMID 8375849 DOI: 10.1176/Ps.44.8.795  1
1993 Breier A, Crane AM, Kennedy C, Sokoloff L. The effects of pharmacologic doses of 2-deoxy-D-glucose on local cerebral blood flow in the awake, unrestrained rat. Brain Research. 618: 277-82. PMID 8374758 DOI: 10.1016/0006-8993(93)91276-X  1
1993 Breier A, Davis OR, Buchanan RW, Moricle LA, Munson RC. Effects of metabolic perturbation on plasma homovanillic acid in schizophrenia. Relationship to prefrontal cortex volume. Archives of General Psychiatry. 50: 541-50. PMID 8317948 DOI: 10.1001/archpsyc.1993.01820190043005  1
1993 Breier A, Kirkpatrick B, Buchanan RW. Clozapine attenuates meta-chlorophenylpiperazine (mCPP)-induced plasma cortisol increases in schizophrenia. Biological Psychiatry. 34: 492-4. PMID 8268334 DOI: 10.1016/0006-3223(93)90241-5  1
1993 Wolkowitz OM, Coppola R, Breier A, Doran AR, Rubinow DR, Berrettini WH, Kling MA, Pickar D. Quantitative electroencephalographic correlates of steroid administration in man. Neuropsychobiology. 27: 224-30. PMID 8232843 DOI: 10.1159/000118985  1
1993 Breier A, Buchanan RW, Irish D, Carpenter WT. Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns. Hospital & Community Psychiatry. 44: 1145-9. PMID 8132186  1
1993 Wolkowitz OM, Weingartner H, Rubinow DR, Jimerson D, Kling M, Berretini W, Thompson K, Breier A, Doran A, Reus VI. Steroid modulation of human memory: biochemical correlates. Biological Psychiatry. 33: 744-6. PMID 8102553 DOI: 10.1016/0006-3223(93)90125-W  1
1993 Hommer D, Weingartner H, Breier A. Dissociation of benzodiazepine-induced amnesia from sedation by flumazenil pretreatment. Psychopharmacology. 112: 455-60. PMID 7871057 DOI: 10.1007/Bf02244894  1
1993 Barancík M, Docolomanský P, Slezák J, Breier A. Overcoming of vincristine resistance in L1210/VCR cells by several corticosteroids. Collateral sensitivity of resistant cells. Neoplasma. 40: 21-5. PMID 7688866  1
1992 Puryear DA, Carson C, Fuentes R, Valls T. Subjective conclusions about schizophrenia. Archives of General Psychiatry. 49: 74-6. PMID 1728253 DOI: 10.1001/Archpsyc.1992.01820010074010  1
1992 Albus M, Zahn TP, Breier A. Anxiogenic properties of yohimbine. II. Influence of experimental set and setting. European Archives of Psychiatry and Clinical Neuroscience. 241: 345-51. PMID 1504111 DOI: 10.1007/BF02191959  1
1992 Albus M, Zahn TP, Breier A. Anxiogenic properties of yohimbine. I. Behavioral, physiological and biochemical measures. European Archives of Psychiatry and Clinical Neuroscience. 241: 337-44. PMID 1504110 DOI: 10.1007/BF02191958  1
1992 Kirkpatrick B, Carpenter WT, Maeda K, Buchanan RW, Breier A, Tamminga CA. Plasma prolactin as a predictor of relapse in drug-free schizophrenic outpatients. Biological Psychiatry. 32: 1049-54. PMID 1467385 DOI: 10.1016/0006-3223(92)90067-A  1
1992 Breier A, Buchanan RW, Elkashef A, Munson RC, Kirkpatrick B, Gellad F. Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Archives of General Psychiatry. 49: 921-6. PMID 1449382 DOI: 10.1001/archpsyc.1992.01820120009003  1
1992 Breier A, Buchanan RW. The effects of metabolic stress on plasma progesterone in healthy volunteers and schizophrenic patients. Life Sciences. 51: 1527-34. PMID 1435061 DOI: 10.1016/0024-3205(92)90563-5  1
1992 Breier A, Schreiber JL, Dyer J, Pickar D. Course of illness and predictors of outcome in chronic schizophrenia: implications for pathophysiology. The British Journal of Psychiatry. Supplement. 38-43. PMID 1389040 DOI: 10.1192/S0007125000297031  1
1992 Poleková L, Barancík M, Mrázová T, Pirker R, Wallner J, Sulová Z, Breier A. Adaptation of mouse leukemia cells L1210 to vincristine. Evidence for expression of P-glycoprotein. Neoplasma. 39: 73-7. PMID 1356238  0.01
1992 Slosarcíková L, Breier A. [Multidrug resistance and the P-glycoprotein]. Bratislavskã© Lekã¡Rske Listy. 93: 146-8. PMID 1356072  1
1992 Goldstein DS, Breier A, Wolkowitz OM, Pickar D, Lenders JW. Plasma levels of catecholamines and corticotrophin during acute glucopenia induced by 2-deoxy-D-glucose in normal man. Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society. 2: 359-66. PMID 1337845 DOI: 10.1007/Bf01831392  1
1992 Breier A, Davis O, Buchanan R, Listwak SJ, Holmes C, Pickar D, Goldstein DS. Effects of alprazolam on pituitary-adrenal and catecholaminergic responses to metabolic stress in humans. Biological Psychiatry. 32: 880-90. PMID 1334713 DOI: 10.1016/0006-3223(92)90177-2  1
1992 Breier A. Effects of alprazolam on metabolic stress-related alterations in HPA axis and catecholamine function in humans European Neuropsychopharmacology. 2: 377. DOI: 10.1016/0924-977X(92)90230-6  1
1992 Breier A, Schreiber JL, Pickar D, Dyer J. Long-term Outcome in Chronic Schizophrenia-Reply Archives of General Psychiatry. 49: 503. DOI: 10.1001/Archpsyc.1992.01820060083016  1
1991 Breier A, Durisová V, Stankovicová T, Mislovicová D, Gemeiner P. Application of adsorption kinetics for estimation of dissociation constants. Journal of Biochemical and Biophysical Methods. 22: 185-93. PMID 1865051 DOI: 10.1016/0165-022X(91)90067-7  1
1991 Dzurba A, Breier A, Slezák J, Stankovicová T, Vrbjar N, Ziegelhöffer A. Influence of calcium antagonists on heart sarcolemmal (Na+ + K(+)-ATPase. Bratislavskã© Lekã¡Rske Listy. 92: 155-8. PMID 1851463  0.01
1991 Monosíková R, Breier A, Ziegelhöffer A, Sima F. Comparison of ATP binding in the active sites of (Na+ + K(+)-ATPase, Mg(2+)-ATPase and Ca(2+)-ATPase with low affinity to calcium from cardiac sarcolemma. Bratislavskã© Lekã¡Rske Listy. 92: 142-5. PMID 1851462  1
1991 Breier A, Davis OR, Buchanan RW. Alprazolam attenuates metabolic stress-induced neuroendocrine and behavioral effects in humans. Psychopharmacology. 104: 479-84. PMID 1780418 DOI: 10.1007/BF02245653  1
1991 Breier A. Panic disorder: clinical features, neurobiology, and pharmacotherapy. New York State Journal of Medicine. 91: 43S-47S. PMID 1771059  1
1991 Carpenter WT, Buchanan RW, Breier A, Kirkpatrick B, Thaker G, Tamminga C. Psychopathology and the question of neurodevelopmental or neurodegenerative disorder. Schizophrenia Research. 5: 192-4. PMID 1760390 DOI: 10.1016/0920-9964(91)90067-2  1
1991 Breier A, Schreiber JL, Dyer J, Pickar D. National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome. Archives of General Psychiatry. 48: 239-46. PMID 1671741 DOI: 10.1001/Archpsyc.1991.01810270051007  1
1991 Carpenter WT, Kurz R, Kirkpatrick B, Hanlon TE, Summerfelt AT, Buchanan RW, Waltrip RW, Breier A. Carbamazepine maintenance treatment in outpatient schizophrenics. Archives of General Psychiatry. 48: 69-72. PMID 1670617 DOI: 10.1001/Archpsyc.1991.01810250071010  1
1991 Dzurba A, Ziegelhoeffer A, Breier A, Vrbjar N, Szekeres L. Increased activity of sarcolemmal (Na+K+)-ATPase is involved in the late cardioprotective action of 7-oxo-prostacyclin. Cardioscience. 2: 105-8. PMID 1652298  1
1990 Wolkowitz OM, Reus VI, Weingartner H, Thompson K, Breier A, Doran A, Rubinow D, Pickar D. Cognitive effects of corticosteroids. The American Journal of Psychiatry. 147: 1297-303. PMID 2399996 DOI: 10.1176/ajp.147.10.1297  1
1990 Wolkowitz OM, Papadopoulos NM, Costello R, Breier A, Doran AR, Pickar D, Rubinow D. Prednisone effects on blood-brain barrier permeability and CNS IgG synthesis in healthy humans. Psychoneuroendocrinology. 15: 155-8. PMID 2359811 DOI: 10.1016/0306-4530(90)90024-4  1
1990 Breier A, Wolkowitz OM, Roy A, Potter WZ, Pickar D. Plasma norepinephrine in chronic schizophrenia. The American Journal of Psychiatry. 147: 1467-70. PMID 2221157 DOI: 10.1176/Ajp.147.11.1467  1
1990 Durisová V, Vrbanová A, Ziegelhöffer A, Breier A. Interaction of Cibacron Blue 3GA and Remazol Brilliant Blue R with the nucleotide binding site of lactate dehydrogenase and (Na+ + K+)-ATPase. General Physiology and Biophysics. 9: 519-28. PMID 2176632  1
1990 Breier A, Monosíková R. [(Na(+)+K+)-ATPase--the molecular basis]. Ceskoslovenskã¡ Fysiologie / ãšStrednã­ ãºStav Biologickã½. 39: 195-206. PMID 2169354  1
1990 Breier A, Durisová V, Monosíková R, Stankovicová T, Vrbanová A, Zúbor V. [The role of Na(+) pump inhibition induced by Ca2(+) ions in the development of pathologic changes during calcium overload in myocardial cells]. Bratislavskã© Lekã¡Rske Listy. 91: 172-6. PMID 2160308  0.01
1990 Weisse CS, Pato CN, McAllister CG, Littman R, Breier A, Paul SM, Baum A. Differential effects of controllable and uncontrollable acute stress on lymphocyte proliferation and leukocyte percentages in humans. Brain, Behavior, and Immunity. 4: 339-51. PMID 2092868 DOI: 10.1016/0889-1591(90)90037-Q  1
1990 Breier A, Paul SM. The GABAA/benzodiazepine receptor: Implications for the molecular basis of anxiety Journal of Psychiatric Research. 24: 91-104. PMID 1980704 DOI: 10.1016/0022-3956(90)90040-W  1
1990 Wolkowitz OM, Rubinow D, Doran AR, Breier A, Berrettini WH, Kling MA, Pickar D. Prednisone effects on neurochemistry and behavior. Preliminary findings. Archives of General Psychiatry. 47: 963-8. PMID 1977371 DOI: 10.1001/Archpsyc.1990.01810220079010  1
1990 Pickar D, Litman RE, Konicki PE, Wolkowitz OM, Breier A. Neurochemical and neural mechanisms of positive and negative symptoms in schizophrenia Modern Problems of Pharmacopsychiatry. 24: 124-151. PMID 1970851 DOI: 10.1159/000418015  1
1990 Schreiber JL, Breier A, Pickar D. Characteristics of patients selected for treatment on a schizophrenia research unit. Hospital & Community Psychiatry. 41: 441-3. PMID 1970550 DOI: 10.1176/Ps.41.4.441  1
1990 Pickar D, Breier A, Hsiao JK, Doran AR, Wolkowitz OM, Pato CN, Konicki PE, Potter WZ. Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia. Archives of General Psychiatry. 47: 641-8. PMID 1694425 DOI: 10.1001/Archpsyc.1990.01810190041006  1
1989 Wolkowitz OM, Doran A, Breier A, Roy A, Pickar D. Specificity of plasma HVA response to dexamethasone in psychotic depression Psychiatry Research. 29: 177-186. PMID 2798596 DOI: 10.1016/0165-1781(89)90032-2  1
1989 Doran AR, Rubinow DR, Wolkowitz OM, Roy A, Breier A, Pickar D. Fluphenazine treatment reduces CSF somatostatin in patients with schizophrenia: correlations with CSF HVA. Biological Psychiatry. 25: 431-9. PMID 2564787 DOI: 10.1016/0006-3223(89)90196-0  1
1989 Breier A. Experimental approaches to human stress research: Assessment of neurobiological mechanisms of stress in volunteers and psychiatric patients Biological Psychiatry. 26: 438-462. PMID 2551397 DOI: 10.1016/0006-3223(89)90066-8  1
1988 Breier A. Stress isn't always bad Hospital and Community Psychiatry. 39: 591. PMID 3402917 DOI: 10.1176/Ps.39.6.591  1
1988 Breier A. Small sample studies: Unique contributions for large sample outcome studies Schizophrenia Bulletin. 14: 589-593. PMID 3064285 DOI: 10.1093/Schbul/14.4.589  1
1988 Pickar D, Breier A, Kelsoe J. Plasma homovanillic acid as an index of central dopaminergic activity: studies in schizophrenic patients Annals of the New York Academy of Sciences. 537: 339-346. PMID 2904783 DOI: 10.1111/J.1749-6632.1988.Tb42118.X  1
1988 Breier A, Nagy LT, Ziegelhöffer A, Monošíková R. Principles of selectivity of sodium and potassium binding sites of the Na+/K+-ATPase. A corollary hypothesis Bba - Biomembranes. 946: 129-134. PMID 2849999 DOI: 10.1016/0005-2736(88)90465-8  1
1988 Breier A, Wolkowitz OM, Doran AR, Bellar S, Pickar D. Neurobiological effects of lumbar puncture stress in psychiatric patients and healthy volunteers. Psychiatry Research. 25: 187-94. PMID 2845460 DOI: 10.1016/0165-1781(88)90050-9  1
1988 Mislovičová D, Gemeiner P, Breier A. Study of porous cellulose beads as an affinity adsorbent via quantitative measurements of interactions of lactate dehydrogenase with immobilized anthraquinone dyes Enzyme and Microbial Technology. 10: 568-573. DOI: 10.1016/0141-0229(88)90052-X  1
1988 Charney DS, Price LH, Breier A. The Course of Panic Attacks and Agoraphobia-Reply Archives of General Psychiatry. 45: 502. DOI: 10.1001/Archpsyc.1988.01800290124016  1
1987 Pickar D, Wolkowitz OM, Labarca R, Doran AR, Breier A, Paul SM. Biochemical alterations produced by neuroleptics in man: studies of plasma homovanillic acid in schizophrenic patients. Psychopharmacology Series. 3: 248-54. PMID 3823092 DOI: 10.1007/978-3-642-71288-3_29  1
1987 Breier A, Wolkowitz OM, Doran AR, Roy A, Boronow J, Hommer DW, Pickar D. Neuroleptic responsivity of negative and positive symptoms in schizophrenia. The American Journal of Psychiatry. 144: 1549-55. PMID 3688278 DOI: 10.1176/Ajp.144.12.1549  1
1987 Wolkowitz OM, Doran AR, Breier A, Roy A, Jimerson DC, Sutton ME, Golden RN, Paul SM, Pickar D. The effects of dexamethasone on plasma homovanillic acid and 3-methoxy-4-hydroxyphenylglycol. Evidence for abnormal corticosteroid-catecholamine interactions in major depression. Archives of General Psychiatry. 44: 782-9. PMID 3632251 DOI: 10.1001/Archpsyc.1987.01800210026004  1
1987 Pickar D, Wolkowitz OM, Doran AR, Labarca R, Roy A, Breier A, Narang PK. Clinical and biochemical effects of verapamil administration to schizophrenic patients. Archives of General Psychiatry. 44: 113-8. PMID 3545130 DOI: 10.1001/Archpsyc.1987.01800140015002  1
1987 Doran AR, Boronow J, Weinberger DR, Wolkowitz OM, Breier A, Pickar D. Structural brain pathology in schizophrenia revisited. Prefrontal cortex pathology is inversely correlated with cerebrospinal fluid levels of homovanillic acid. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 1: 25-32. PMID 3509912 DOI: 10.1016/0893-133X(87)90006-6  1
1987 Breier A, Arora PK, Wolkowitz OM, Pickar D, Paul SM. Metabolic Stress Produces Rapid Immunosuppression in Humans Archives of General Psychiatry. 44: 1108-1109. PMID 3500689 DOI: 10.1001/Archpsyc.1987.01800240084014  1
1987 Breier A, Monosíková R, Ziegelhöffer A. Modification of primary amino groups in rat heart sarcolemma by 2,4,6-trinitrobenzene sulfonic acid in respect to the activities of (Na+ + K+)-ATPase, Na+-ATPase and pNPPase. Function of the potassium binding sites General Physiology and Biophysics. 6: 103-108. PMID 3036642  1
1987 Wolkowitz OM, Rubinow DR, Breier A, Doran AR, Davis C, Pickar D. Prednisone decreases CSF somatostatin in healthy humans: implications for neuropsychiatric illness. Life Sciences. 41: 1929-33. PMID 2889125 DOI: 10.1016/0024-3205(87)90745-4  1
1987 Breier A, Albus M, Pickar D, Zahn TP, Wolkowitz OM, Paul SM. Controllable and uncontrollable stress in humans: alterations in mood and neuroendocrine and psychophysiological function. The American Journal of Psychiatry. 144: 1419-25. PMID 2823617 DOI: 10.1176/Ajp.144.11.1419  1
1987 Monosíková R, Ziegelhöffer A, Breier A, Dzurba A, Vrbjar N. Modulation of the activity of (Na+ + K+)-ATPase, Mg2+-APase and Ca2+-ATPase with low calcium affinity in myocardial sarcolemma using ribose-5-phosphate Bratislavske Lekarske Listy. 88: 28-33. PMID 2822208  1
1987 Monosíková R, Ziegelhöffer A, Breier A. Interaction of ATP with the active sites of ATPases in heart sarcolemma. Role of the hydroxylic group in position two on the ribose moiety General Physiology and Biophysics. 6: 193-196. PMID 2820838  1
1987 Gemeiner P, Barteltová L, Šoltés L, Breier A. Size-exclusion effect of a substrate upon kinetics of trypsin immobilized on porous bead cellulose. 2. Influence of hydrodynamic diameter of substrate Enzyme and Microbial Technology. 9: 44-46. DOI: 10.1016/0141-0229(87)90047-0  1
1986 Charney DS, Heninger GR, Price LH, Breier A. Major depression and panic disorder: Diagnostic and neurobiological relationships Psychopharmacology Bulletin. 22: 503-511. PMID 3774939  1
1986 Breier A, Charney DS, Heninger GR. Agoraphobia With Panic Attacks: Development, Diagnostic Stability, and Course of Illness Archives of General Psychiatry. 43: 1029-1036. PMID 3767595 DOI: 10.1001/Archpsyc.1986.01800110015003  1
1986 Breier A, Charney DS, Heninger GR. Intravenous diazepam fails to change growth hormone and cortisol secretion in humans Psychiatry Research. 18: 293-299. PMID 3749390 DOI: 10.1016/0165-1781(86)90014-4  1
1986 Pickar D, Labarca R, Doran AR, Wolkowitz OM, Roy A, Breier A, Linnoila M, Paul SM. Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment. Archives of General Psychiatry. 43: 669-76. PMID 3718170 DOI: 10.1001/Archpsyc.1986.01800070059008  1
1986 Doran AR, Breier A, Roy A. Differential diagnosis and diagnostic systems in schizophrenia. The Psychiatric Clinics of North America. 9: 17-33. PMID 3515329  1
1986 Charney DS, Breier A, Jatlow PI, Heninger GR. Behavioral, biochemical, and blood pressure responses to alprazolam in healthy subjects: Interactions with Yohimbine Psychopharmacology. 88: 133-140. PMID 3081923 DOI: 10.1007/Bf00652229  1
1986 Vrbjar N, Breier A, Ziegelhöffer A, Dzurba A, Soós J. Effect of calcium on the structure-function relationship of (Na+ + K+)-ATPase in cardiac sarcolemma General Physiology and Biophysics. 5: 545-549. PMID 3026889  1
1986 Breier A, Monosíková R, Ziegelhöffer A, Dzurba A. Heart sarcolemmal (Na+ + K+)-ATPase has an essential amino group in the potassium binding site on the enzyme molecule General Physiology and Biophysics. 5: 537-544. PMID 3026888  1
1986 Wolkowitz OM, Doran AR, Breier A, Cohen MR, Pickar D. Endogenous opioid regulation of hypothalamo-pituitary-adrenal axis activity in schizophrenia. Biological Psychiatry. 21: 366-73. PMID 2869791 DOI: 10.1016/0006-3223(86)90164-2  1
1986 Wolkowitz OM, Pickar D, Doran AR, Breier A, Tarell J, Paul SM. Combination alprazolam-neuroleptic treatment of the positive and negative symptoms of schizophrenia. The American Journal of Psychiatry. 143: 85-7. PMID 2867690 DOI: 10.1176/Ajp.143.1.85  1
1986 Ziegelhoffer A, Vrbjar N, Breier A. How do the ATPases in cardiac cell membrane work? Biomedica Biochimica Acta. 45. PMID 2421715  1
1986 Ziegelhoffer A, Breier A, Monosikova R. Contribution to the problem of selective binding of cations of alkaline metals and of alkaline earth metals to biological structures Bratislavske Lekarske Listy. 85: 258-264. PMID 2420420  1
1986 Breier A, Gemeiner P, Ziegelhoffer A. Quantitative criterion for evaluation of hydrophobic sorbents Journal of Chromatography - Biomedical Applications. 95-101. DOI: 10.1016/S0378-4347(00)80826-9  1
1986 Gemeiner P, Polák C, Breier A, Petruš L, Beneš MJ. Size-exclusion effect of a substrate upon kinetics of trypsin immobilized on porous bead cellulose. 1. Influence of distribution coefficient of a substrate Enzyme and Microbial Technology. 8: 109-114. DOI: 10.1016/0141-0229(86)90082-7  1
1985 Ziegelhöffer A, Breier A, Vrbjar N, Holec V. Regulation of sarcolemmal Ca2+-ATPase activity in the heart based on the differing effect of sodium and potassium ions Bratislavske Lekarske Listy. 83: 301-307. PMID 3157429  1
1985 Roy A, Breier A, Doran AR, Pickar D. Life events in depression. Relationship to subtypes. Journal of Affective Disorders. 9: 143-8. PMID 2932487 DOI: 10.1016/0165-0327(85)90093-X  1
1985 Breier A, Charney DS, Heninger GR. The diagnostic validity of anxiety disorders and their relationship to depressive illness American Journal of Psychiatry. 142: 787-797. PMID 2861752 DOI: 10.1176/Ajp.142.7.787  1
1985 Breier A, Rosca D. (Some results of the study of alluvium sources and the effects of anti-erosion works in small basins) Cercetari Geomorfologice Pentru Lucrarile De Imbunatatiri Funciare. 277-283.  1
1984 Charney DS, Heninger GR, Breier A. Noradrenergic Function in Panic Anxiety: Effects of Yohimbine in Healthy Subjects and Patients With Agoraphobia and Panic Disorder Archives of General Psychiatry. 41: 751-763. PMID 6742977 DOI: 10.1001/Archpsyc.1984.01790190025003  1
1984 Ziegelhöffer A, Breier A, Dzurba A, Vrbjar N, Monosíková R. Modelling of the kinetics of inhibition of structurally-bound enzyme systems at the subcellular up to the organ level during direct enzyme-inhibitor interactions and in receptor-mediated reactions Bratislavske Lekarske Listy. 81: 294-301. PMID 6704767  1
1984 Breier A, Ginsberg EM, Charney DS. Seminal emission induced by tricyclic antidepressant American Journal of Psychiatry. 141: 610-611. PMID 6703149  1
1984 Breier A, Astrachan BM. Characterization of schizophrenic patients who commit suicide American Journal of Psychiatry. 141: 206-209. PMID 6691481 DOI: 10.1176/Ajp.141.2.206  1
1984 Breier A, Charney DS, Heninger GR. Major Depression in Patients With Agoraphobia and Panic Disorder Archives of General Psychiatry. 41: 1129-1135. PMID 6508503 DOI: 10.1001/Archpsyc.1984.01790230015002  1
1984 Breier A, Gemeiner P, Ziegelhöffer A. Simple estimation of carrier binding capacity using sorption kinetics curve-fitting Journal of Biochemical and Biophysical Methods. 9: 267-275. PMID 6470404 DOI: 10.1016/0165-022X(84)90031-9  1
1984 Breier A, Strauss JS. The role of social relationships in the recovery from psychotic disorders American Journal of Psychiatry. 141: 949-955. PMID 6465369 DOI: 10.1176/Ajp.141.8.949  1
1984 Breier A, Charney DS, Nelson JC. Seizures induced by abrupt discontinuation of alprazolam American Journal of Psychiatry. 141: 1606-1607. PMID 6150649  1
1984 Breier A, Gemeiner P, Marko V, Drobnica L. Selective chemisorbents. Part 3: Selective binding of thiols to benzaldehyde derivatives of cellulose Reactive Polymers, Ion Exchangers, Sorbents. 2: 189-196. DOI: 10.1016/0167-6989(84)90134-X  1
1983 Breier A, Strauss JS. Self-control in Psychotic Disorders Archives of General Psychiatry. 40: 1141-1145. PMID 6625862 DOI: 10.1001/archpsyc.1983.01790090103016  1
1983 Ziegelhöffer A, Breier A, Dzurba A, Vrbjar N. Selective and reversible inhibition of heart sarcolemmal (Na+ + K+)-ATPase by p-bromophenyl isothiocyanate. Evidence for a sulfhydryl group in the ATP-binding site of the enzyme General Physiology and Biophysics. 2: 447-456. PMID 6088362  1
1982 Gastescu P, Breier A. ( Romanian coastal lakes - hydrological characteristics, human modifications and their utilization, Razim Sinoe Lakes, Hagieni, Tatlageac, Tasaul, Gargalic, Techirghiol) Revue Roumaine De Geologie, Geophysique Et Geographie, Geographie. 26: 61-70.  1
1981 Breier A, Hitzemann RJ, Hirschowitz J, Garver DL. Kinetic analysis of platelet monoamine oxidase in chronic schizophrenia Life Sciences. 28: 1947-1951. PMID 7253802 DOI: 10.1016/0024-3205(81)90303-9  1
1949 Brenner W, Breier A. Beiträge zur Kenntnis des Eisen- und Kupferstoffwechsels im Kindesalter - Zugleich ein Beitrag zur Kenntnis der kindlichen Schizophrenie Zeitschrift FüR Kinderheilkunde. 66: 620. DOI: 10.1007/BF00439997  1
1900 Breier A. Glasgefässe mit Asbestüberzug Zeitschrift FüR Analytische Chemie. 39: 580. DOI: 10.1007/BF01344573  1
Show low-probability matches.